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Recommendation Grades and the Directionality of Topic Updates over Time 
(Under the direction of Russell Harris) 
 
Background: The U.S. Preventive Services Task Force has provided evidence-based 
recommendations to primary care clinicians on the use of preventive services for almost 30 
years. In the past, the Task Force has been criticized for being too conservative in issuing 
recommendations in favor of the use of preventive services.  Several recent criticisms, however, 
have focused on recommendations considered too liberal in the promotion of services. 
Objective:  To identify trends in the overall allocation of recommendation grades and in the 
frequency of positive changes (i.e. the issuance of more favorable recommendations) and 
negative changes (i.e. the issuance of less favorable recommendations) made to 
recommendations when updating topics.    
Methods:  All recommendations issued by the Task Force from January 1996 to June 2017 were 
collected.  Point-based and categorization-based methods were used to evaluate the directionality 
of change for recommendations issued on updated topics.   
Results:  The proportion of negative recommendations issued over the past several years has 
substantially decreased (to 10.1% of recommendations issued from 2013 to 2017 compared to 
22.4% from 2006 to 2012 and 23.8% from 2001 to 2005), while the proportion of “I” statements 
has increased (to 46.1% from 2013 to 2017 compared to 33.7% from 2006 to 2012 and 36.6% 
from 2001 to 2005).  The proportion of recommendations assigned positive letter grades has 
slightly increased over time (to 38.2% of recommendations issued from 2013 to 2017 compared 
to 36.7% from 2006 to 2012 and 33.7% from 2001 to 2005).  Furthermore, negative changes 
(resulting in the decreased promotion and/or increased discouragement of preventive services) 
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made to recommendations issued on updated topics have become less common over time (as 
assessed by two different methods). Conversely, positive changes (resulting in the increased 
promotion and/or decreased discouragement of preventive services) have become more common 
over the past several years.  Finally, the Task Force has increasingly chosen not to update 
negative recommendations for previously evaluated interventions or populations (6 out of 8 of 
these dropped negative recommendations have occurred since 2013).  
Conclusions:  Several potential factors may have contributed to the longitudinal changes in the 
issuance of Task Force recommendations observed in this study. These factors include changes 
in evidence for evaluated services, changes in the methodology for assigning recommendations, 
political pressures, the link between coverage policy and recommendations, and changes in the 
thresholds used to delineate recommendation grades.  Further research is needed to assess the 
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 The U.S. Preventive Services Task Force (USPSTF) is an independent panel of experts in 
primary care and prevention that develops recommendations for clinical preventive services 
based on systematic reviews of evidence related to their effectiveness.  First convened in 1984, 
the Task Force has provided guidance to clinicians on the use of preventive services for nearly 
30 years since it published the first edition Guide to Clinical Preventive Services in 1989 
(hereafter referred to as the Guide).1   Today, the mission of the Task Force remains unchanged: 
“to improve the health of all Americans by making evidence-based recommendations about 
clinical preventive services and health promotion.”2  Its recommendations cover a wide range of 
preventive services offered in the primary care setting or referable by a primary care clinician 
such as screenings, counseling services, and preventive medications.  Evidence reviews form the 
scientific basis for assessing the certainty and magnitude of benefits and harms associated with 
the routine provision of a preventive service in a particular population.  Depending on the 
certainty of evidence regarding this balance for a service, the Task Force may issue a 
recommendation for or against its use. In other instances, the Task Force may deem that the 
existing evidence base is not sufficient to make a recommendation. 
  The Task Force, thus, has a tripartite set of responsibilities in providing guidance to 
primary care clinicians about which preventive services to routinely offer their patients.  First, it 
has the responsibility of making recommendations in favor of routinely offering services likely 
to yield net health benefit.  Secondly, it has the responsibility of making recommendations 
against the routine provision of services from which patients are unlikely to benefit or may even 
be harmed. Finally, when the cumulative evidence related to a preventive service is insufficient 
to evaluate its balance of harm and benefits with certainty, the Task Force has the responsibility 
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of stating as such.  In these cases, a summary of what is known about the service is important for 
informing clinical practice and for guiding future research efforts. 
  The current system of assigning grades to specific recommendations addresses these 
responsibilities. For each recommendation, the Task Force evaluates both the certainty and 
strength of evidence for or against the intervention.3,4 To evaluate the magnitude of net benefit, 
the Task Force considers both the magnitude of benefit and the magnitude of harm that would 
result from implementing the preventive service in a primary care population or subpopulation.  
While metrics such as the “number needed to treat” or “number needed to harm” may be 
considered in this estimation, the Task Force does not use specific criteria to differentiate 
between levels of net benefit.4  Specific criteria, however, are used to evaluate the certainty that 
the assessment of the magnitude of net benefit is correct.  
  A recommendation grid guides the selection of the appropriate grade for a given 
recommendation based on both the certainty and magnitude of net benefit (Table 1). 
Standardized language accompanies each grade.5  For both “A” and “B” recommendations, the 
Task Force recommends that clinicians offer or provide the service. For “C” recommendations, 
the Task Force recommends that clinicians offer or provide the service to selected patients based 
on professional judgment and patient preferences.  For “D” recommendations, the Task Force 
discourages the use of the service. Finally, for services where the certainty of the magnitude of 
net benefit is low, the Task Force issues an “I” statement and recommends that if the service is 






Table 1.  U.S. Preventive Service Task Force Recommendation Grid4 
Certainty of 
Net Benefit 
Magnitude of Net Benefit 
Substantial Moderate Small Zero/Negative 
High A B C D 
Moderate B B C D 
Low I 
 
  Historically, the Task Force has been criticized for a perception that its evidence 
threshold is too high for issuing recommendations in favor of the routine use of services.6  
Recently, however, the Task Force has faced a different criticism for not being strict enough in 
issuing positive recommendations. One critic has argued that several recommendations issued 
over the past few years have been “far more liberal in promoting interventions.”7   
  In late 2016, for instance, the Task Force updated its recommendations for depression 
screening in adults, adolescents, and children.8,9 Previously, the Task Force had issued “B” 
recommendations for routinely screening adults and adolescents (ages 12 to 18) for depression 
when support systems are in place to ensure accurate diagnosis, effective treatment, and follow-
up.10,11  Despite concern from critics who argued that these recommendations should be 
reconsidered, in part, because no randomized controlled trials have directly demonstrated that 
depression screening benefits primary care patients12, the USPSTF reaffirmed them.  
Furthermore, the Task Force expanded its recommendations in favor of depression screening in 
adults to include pregnant and post-partum women and omitted its “C” recommendations for the 
selective screening of patients when depression care supports are not in place. These updated 
recommendations have received similar criticisms, including charges that the Task Force did not 
adequately consider the harms associated with screening and that it relied too heavily on indirect 
evidence to evaluate the benefits of screening.13 
   Similarly, other USPSTF recommendations issued within the past few years have been 
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criticized for expanding the endorsement of preventive services on the basis of evidence deemed 
inadequate to estimate the magnitude of benefit with sufficient certainty.  In 2013, for instance, 
the “B” recommendation for low-dose CT screening in high-risk current and former smokers 
generated significant dissent.14 This recommendation represented a new endorsement of this 
service in comparison to the “I” statement the Task Force had previously issued for all 
asymptomatic patients.14  Among the criticisms lodged against the recommendation included an 
assertion that its reliance on a single study and simulation models introduced significant 
uncertainty in the overall estimate of the magnitude net benefit.15 Furthermore, critics argued that 
because of the significant harms associated with low-dose CT screening, even small differences 
in screening conditions outside a trial setting could alter the fine balance between harms and 
benefits in an unfavorable direction.15  
  The 2016 recommendation statement on statins for the prevention of cardiovascular 
disease in adults has also faced criticism.16  These updated recommendations included a “B” 
recommendation for the initiation of statins in a set of high-risk adults, expanding upon the prior 
recommendations in favor of screening for lipid disorders in adults at increased risk of coronary 
heart disease.17 Detractors of the updated recommendations argue that the lack of access to 
primary data from statin clinical trials may have led to an overestimation of the benefits of statin 
use.18  Furthermore, they argue that the evidence regarding the harms from statins is incomplete, 
particularly because many of the trials included in the USPSTF evidence review did not report 
on common statin side effects such as muscle pains and weakness.18  They additionally contend 
that potential harms associated with statin use in healthy persons, such as those related to the 




    While substantial attention has been drawn to updated recommendations made in favor of 
the routine provision of preventive services, growing concern has also been directed toward the 
overuse of services associated with net harm. Based on a call for U.S. medical specialty societies 
to identify the top overused tests and treatments with little meaningful benefit or potential net 
harm20,  the Choosing Wisely campaign had been at the forefront of an international discussion 
about the overuse of medical services.21  Since 2012, over 70 medical specialty societies have 
created lists of the top medical services in their specialty for which there is strong evidence of 
overuse and significant potential for harm.22  
  Despite the widespread publicity the Choosing Wisely campaign has brought to the 
concept of medical overuse, the recommendations included on these lists are not necessarily 
based on rigorous evidence assessments.  One study, for instance, concluded that a majority of 
primary care–relevant Choosing Wisely recommendations are based on expert consensus or 
disease-oriented evidence.23  Admittedly, the Choosing Wisely campaign notes that these 
recommendations are intended “to spur conversation about what is appropriate and necessary 
treatment” and should not be used to establish coverage decisions.24  Thus, there is a need for the 
development of evidence-based recommendations against the use medical services shown to 
have no benefit or cause significant harm.   For preventive services, the USPSTF addresses this 
need by assigning a “D” grade to services evaluated, with at least moderate certainty, to have 
zero or negative net benefit.5  
  In 2012, the USPSTF issued perhaps its most publicized “D” recommendation when it 
expanded its recommendation against the use of PSA-based screening for prostate cancer to 
include men of all ages.25 An editorial published alongside the USPSTF recommendation 
statement vehemently critiqued the recommendation arguing that the Task Force had 
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underestimated the benefits and overestimated the harms of prostate cancer screening.26  The 
debate surrounding the recommendation even entered the political realm when former Senator 
Jeff Sessions (R-AL) introduced S.Res. 251 to the Senate in 2013.27 The resolution contended 
that the USPSTF “should reevaluate its recommendation against PSA-based screening for 
prostate cancer men in all age groups … and seriously engage with specialists, including 
urologists and oncologists, as it reevaluates its recommendation.”27 Although the resolution did 
not make it out of committee, its introduction to the Senate highlights the considerable 
controversy this recommendation generated among both the medical community and the general 
public.   
   The recently issued draft recommendation statement for prostate cancer screening 
rescinds the “D” recommendation against PSA-based screening in men ages 55 to 69 years old.28 
Instead, the Task Force has proposed a  “C” recommendation advocating that clinicians inform 
these men about the benefits and harms of screening, including a small potential mortality 
benefit and potential harms such as false-positive results, overdiagnosis and overtreatment, and 
treatment complications. This change, coupled with several other recent recommendation 
changes, including those discussed above, adds credence to the supposition that Task Force 
recommendations over the past several years have tended to move in a direction toward 
promoting the increased use of preventive services and away from discouraging the use of 
services.  
  This potential trend, however, has not been formally assessed.  In this report, I aim to 
evaluate the hypothesis that USPSTF recommendations have trended toward promoting the 
increased use of preventive services and away from discouraging the use of preventive services, 
particularly over the past several years.  Two primary questions are addressed.  First, how has the 
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overall allocation of recommendation grades changed over time?  Second, have updated 
recommendations for previously evaluated topics trended in a particular direction? More 
specifically, how frequently has the directionality of change been in a positive direction, either 
recommending in favor of the use of more preventive services or recommending against the use 
of fewer services?  Correspondingly, how frequently has the directionality of change been in a 
negative direction, either recommending in favor of the use of fewer preventive services or 
recommending against the use of more services? 
 
Table 2.  Definitions for key terms used throughout paper   
Term Definition 
Topic 
An evaluated preventive service or set of preventive services evaluated 
together, usually for a single condition or disease. Evaluated preventive 
services may include screening tests, counseling services, preventive 
medications, or a combination of services. 
Recommendation 
statement 
Structured statement covering a preventive services topic and including 
one or more individual recommendations with associated letter grades. In 
addition to recommendations, recommendation statements include the 
rationale for each recommendation, guidance for clinicians who want to 
use the recommendations, and a discussion of the evidence.  
Individual 
Recommendation 
Single recommendation regarding the use of a preventive service in a 
specific population with an associated letter grade.  
Letter grade 
Grade assigned to each individual recommendation. Indicates the strength 
of the recommendation for or against the routine use of the preventive 
service.  Each letter grade (A, B, C, D, I) has a standard definition and 
suggestions for practice (see Table 3). 
Updated topic / 
topic update 
Updated set of recommendations for a previously evaluated topic (or 
topics if the services were previously evaluated separately).  
New topic 
Preventive service or set of preventive services evaluated by the Task 
Force for the first time.  
Inactive topic 
Topic the Task Force has chosen not to update. Topics may be inactivated 
if they are no longer relevant to clinical practice, as a result of changes in 
technology, or for other reasons.  
Referred topic 
Topic previously evaluated by the Task Force, but since referred to another 
organization. The Task Force, for instance, now refers to the Advisory 







Table 3.  Current letter grades, definitions, and suggestions for practice.29 
Grade Definition Suggestions for practice 
A 
The USPSTF recommends the service. 
There is high certainty that the net benefit is 
substantial. 
Offer or provide this service. 
B 
The USPSTF recommends the service. 
There is high certainty that the net benefit is 
moderate or there is moderate certainty that 
the net benefit is moderate to substantial. 
Offer or provide this service. 
C 
The USPSTF recommends selectively 
offering or providing this service to 
individual patients based on professional 
judgment and patient preferences. There is 
at least moderate certainty that the net 
benefit is small. 
Offer or provide this service for 
selected patients depending on 
individual circumstances. 
D 
The USPSTF recommends against the 
service. There is moderate or high certainty 
that the service has no net benefit or that the 
harms outweigh the benefits. 
Discourage the use of this service. 
I 
statement 
The USPSTF concludes that the current 
evidence is insufficient to assess the balance 
of benefits and harms of the service. 
Evidence is lacking, of poor quality, or 
conflicting, and the balance of benefits and 
harms cannot be determined. 
Read the clinical considerations 
section of USPSTF 
Recommendation Statement. If the 
service is offered, patients should 
understand the uncertainty about 











Collection of current and historical USPSTF recommendation statements 
  On its official website, the USPSTF lists the set of preventive services topics for which it 
has published specific recommendations.30 For each topic, the USPSTF website provides 
hyperlinks to the most recently published recommendation statement and to additional 
supporting documents such as the final research plan, the final evidence review, an evidence 
summary, and a one-page clinical summary.  Using these hyperlinks, I obtained the most 
recently published recommendation statement for each listed topic.  I last consulted the USPSTF 
website on June 1, 2017.  
  While the USPSTF website archives older versions of recommendation statements for 
many topics, not all historical recommendation statements are referenced or available for 
download. For this reason, I used the most recently issued recommendation statement for each 
topic to identify the previously issued recommendation statement (or statements) on the same 
topic. In most cases, the abstract of the recommendation statement referenced the year in which 
the previous recommendation statement had been issued.  For recommendation statements 
published in 2010 and later, a specific section within each statement compares the updated 
recommendations with the previously issued recommendations on the same topic.  Using this 
information, I searched PubMed to identify historical recommendation statements when they 
were not available on the USPSTF website.  In most instances, I was able to retrieve 
recommendation statements that had been published in peer-reviewed academic journals. In a 
few cases, however, I could only obtain recommendation statements that had been released 
directly by the Agency for Healthcare Research and Quality (AHRQ).  I collected 
recommendation statements in reverse chronological order, mapping them back either to 
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recommendation statements issued on new topics or to recommendations included in the second 
edition of the Guide (published in 1996).31    
 
Data extraction 
  I extracted data from each identified recommendation statement and from the topic 
chapters and tables of ratings in the second edition of the Guide.  For each recommendation 
statement or chapter, I documented its title, its publication date, the status of the recommendation 
statement (historical or current), a determination of whether the topic had previously been 
evaluated (updated topic or new topic), and the current topic status (active, inactive, or referred).  
For each individual recommendation, I extracted the text of the recommendation summary, its 
associated letter grade, and the targeted population. 
 
Considerations for recommendations included in the second edition of the Guide 
  Extracting data from recommendations published in the second edition of the Guide 
presented several unique challenges (see Appendix A for full discussion).  First, the chapters 
written for each topic included in the Guide do not always clearly outline the individual 
recommendations and their associated letter grades. For this reason, I used the tables of ratings 
(included in Appendix A of the second edition of the Guide) to delineate the individual 
recommendations issued on each topic. I referenced the chapter associated with each table to 
further interpret individual recommendations. Second, several topics included in the second 
edition of the Guide have not been updated by the Task Force (for a list of these topics, see 
Appendix B, Table B15).  I only extracted data for recommendations issued on topics that have 
since been updated.  Third, the methodology for assigning recommendation grades to counseling 
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interventions has substantially evolved over time.  The second edition of the Guide, however, 
provided sufficient information to interpret its recommendations on counseling interventions in 
the context of the current grading system (see Appendix A).  Finally, prior to issuing its first 
recommendations in 2001, the third Task Force significantly updated the recommendation 
grading system.32  These changes included the establishment of the “I” letter grade and an update 
of  the “C” letter grade definition.  For “C” recommendations issued in the second edition of the 
Guide, the Task Force concluded that current evidence was insufficient to recommend for or 
against the routine inclusion of a preventive service in the periodic health exam, but that 
recommendations for the service could be made on other grounds.33  Unless the text associated 
with a “C” recommendation issued in the second edition of the Guide clearly indicated 
otherwise, I interpreted it as a recommendation neither for nor against the routine use of a service 
when comparing it to updated recommendations. 
 
Summary of active USPSTF recommendations 
    I tabulated the current number of active topics and individual recommendations listed on 
the USPSTF website as of June 1, 2017.  I then calculated the number and proportion of active 
recommendations assigned each letter grade. I further calculated the number and proportion of 
active topics with at least one negative (“D”) recommendation, positive (“A” or “B”) 
recommendation, “C” recommendation, or “I” statement.  Finally, I compiled a summary of all 
active recommendations published within the past five years (from June 1, 2012 to June 1, 2017), 
roughly the set of recommendations eligible for inclusion in the National Guidelines 




Assessing changes in the allocation of USPSTF recommendation grades over time 
    I calculated the number and proportion of USPSTF recommendations issued by letter 
grade for each year from 2001 to 2017.  Given the small number of recommendations issued in 
any single year and the high variability seen between years, I aggregated individual 
recommendations into three time periods based on their publication date:  January 2001 to 
December 2005, January 2006 to December 2012, and January 2013 to June 2017.   I chose these 
time periods to roughly divide the number of individual recommendations published in each time 
period into thirds.  I used these same time periods for subsequent analyses, as described below.  
In all cases, I varied the boundaries of the time periods by one to two years in either direction 
and evaluated how doing so affected key observations.  
 
Mapping topic updates to previously issued recommendation statements 
   For each recommendation statement issued on an updated topic, I compared the updated 
recommendations to the most recent previously issued recommendations on the topic. The topic 
covered by an updated recommendation statement, however, does not always precisely 
correspond to the topic covered by a single previously issued recommendation statement.  For 
cases in which the topic covered by an updated recommendation statement diverged from a 
previously reviewed topic, I only compared the relevant previously issued recommendations to 
the updated recommendations on the topic. Similarly, for cases in which the topic covered by an 
updated recommendation statement included recommendations covered by two or more 
previously issued recommendation statements, all relevant previously issued individual 
recommendations were used for making comparisons.  Illustrative examples of this strategy are 
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provided in Appendix A.  
 
Point-based method for assessing the directionality of topic updates 
    When recommendations for a topic are updated, the specific interventions and 
subpopulations covered by individual recommendations frequently change. As a consequence, 
one-to-one relationships between updated individual recommendations and previously issued 
individual recommendations do not always exist.  For this reason, I used a point-based method to 
measure the directionality of changes made to recommendations at the topic level. For every 
recommendation statement issued on an updated topic, I assigned each individual 
recommendation a point value ranging from -1 to +1 based on its letter grade (Table 4).   
  The method for assigning points to individual recommendations was chosen for its 
simplicity.  While the recommendation grading system has undergone significant revisions since 
the publication of the second edition of the Guide, the essence of the grade definitions for “A”, 
“B”, and “D” recommendations has remained relatively stable over time.5 Similarly, while the 
standard recommendation language and suggestions for practice associated with “C” 
recommendations have undergone periodic revisions, the requirement of at least “moderate 
certainty” (or at least “fair evidence” prior to May 2007) of small net benefit in the assignment of 
a “C” letter grade has remained stable since the third Task Force significantly updated the 
methods for assigning letter grades.3,5 In the grading system used by the second Task Force, a 
“C” letter grade was assigned when insufficient evidence was available to determine whether or 
not the routine use of an intervention would improve clinical outcomes.33 Given that “I” 
statements and have consistently indicated that the Task Force either found insufficient evidence 
to make a judgment about the effectiveness of an intervention or sufficient evidence that 
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magnitude of net benefit of routinely offering a service is small, all “I” statements and “C” 
recommendations were assigned a point value of zero.  For negative recommendations, the 
second Task Force issued one of two letter grades (“D” or “E”) based on the level of evidence 
against the routine use of the preventive service. In the current grading system, however, only a 
single negative letter grade (“D”) exists. For this reason, all “D” and “E” recommendations 

















  For each topic update, I calculated two different “directionality scores” reflective of the 
overall change in the letter grades assigned to individual recommendations on a topic compared 
to the most recent previously issued recommendations on the same topic (Figure 1).  Based on 
publication date, I aggregated topic updates into three time periods as specified above. For each 
time period and method for calculating the directionality score, I tabulated the number and 
proportion topic updates assigned positive, neutral, and negative directionality scores. 
Table 4. Assignment of point values to 
individual recommendations 



















Figure 1. Calculation of point-based directionality scores for topic updates 
 
Classification-based method for assessing the directionality of topic updates    
  To supplement the point-based directionality scores, I additionally used a classification-
based system to assess the directionality of topic updates.  For these assessments, I only 
considered recommendations that applied to interventions and populations covered by both the 
updated and previously issued sets of recommendations on a topic.  For each topic update, I 
individually categorized both the updated and prior sets of recommendations based on whether 
the Task Force had recommended in favor of (“positive”), against (“negative”), or neither for nor 
against (“neutral”) the use of the preventive services under consideration (Figure 2, Step 1 and 
Step 2).  In making these assessments, “C” recommendations were considered “neutral”, even 
though the definition of this letter grade has changed over time.  A set of recommendations only 
received a “neutral” overall assessment if it included no positive or negative recommendations.  
When a set of recommendations included both positive and negative recommendations, I 
prioritized the positive recommendations in making an overall assessment (see Appendix A for 
examples).   
  Based on these assessments, I assigned a “letter score” to each topic update reflective of 
the change in letter grades assigned to recommendations for preventive services covered by both 
Directionality score (Method 1)  
= Mean point value of updated recommendations  
– Mean point value of previously issued recommendations 
Directionality score (Method 2) 
= Sum of points for updated recommendations  
– Sum of points for previously issued recommendations 
16 
 
the updated and prior sets of recommendations (Figure 2, Step 3).  If both the updated and prior 
set of recommendations for a topic received a “positive” overall assessment, I evaluated whether 
the letter grades for the considered recommendations became more positive, less positive, or 
remained equally as positive.  Similarly, if both the updated and prior set of recommendations 
received a “negative” overall assessment, I evaluated whether the letter grades for the considered 
recommendations became more negative, less negative, or remained equally as negative.  
Finally, I secondarily categorized each topic update based on the directionality of its assigned 
letter score (Figure 2, Step 4).  
  Specific rules were developed for issuing letter scores in special cases, such as when 
linkages between prior and updated recommendations could not be easily inferred. These rules 
and illustrative examples are provided in Appendix A. In general, however, when the change in 
recommendations was unclear, I assigned a neutral letter score.  Furthermore, I did not consider a 
previously issued individual recommendation on a topic if the Task Force chose not to update it.  
Similarly, I did not consider individual recommendations for newly evaluated interventions or 
populations. On two occasions, however, I assigned a letter score of “negative to positive” when 
the Task Force issued a single positive recommendation for an intervention in a high-risk 
population after having previously issued a single negative recommendation for its use in a low-










Figure 2. Approach to assigning letter scores to recommendation statements for updated topics. 
    
  For topic updates assigned a variant of a “positive to positive” letter score, I additionally 
assigned an “intensity score.”  The intensity score reflects the change in the breadth of preventive 
services issued a positive recommendation for a given topic irrespective of the strength of the 
letter grades assigned to the recommendations.  Recommendations for screening interventions, 
for instance, can apply to populations of different sizes, suggest varying screening intervals, 
and/or specify screening modalities of differing sensitivities.  In many cases, the Task Force does 
not specifically recommend a single intervention, screening interval, or other characteristic of a 
preventive service related to its intensity, but does discuss clinical considerations relevant to 
these characteristics within the text of the recommendation statement. For the purposes of 
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assigning an intensity score to a topic update, I only considered clearly recommended 
characteristics of a preventive service. The criteria used to assign each of the three possible 
intensity scores are outlined in Table 5.  Several examples of the assignment of intensity scores 
to topic updates are included in Appendix A.  For a subset of topic updates, a second researcher 
(RH) independently assigned letter scores and intensity scores. Differences in the assignment of 
these scores were resolved through discussion. This process secondarily led to the refinement of 
the classification system.  
 
 
     For all topic updates issued from 2001 to 2017, I calculated the number and proportion 
issued each of the possible letter scores.  I then aggregated topic updates into three time periods 
as specified above. I calculated the number and proportion of topic updates assigned positive, 
neutral, and negative letter scores for each time period.  For topic updates issued intensity scores, 
I similarly calculated the number and proportion topic updates assigned each of the possible 
intensity scores stratified by time period. 
Table 5.  Non-exhaustive list of criteria used to assign intensity scores to topic updates (only 
changes in positive recommendations considered) 
Same intensity (all criteria must apply) 
• Recommendations apply to same population 
• Recommended screening or counseling intervals remain unchanged 
• Recommended ages for starting or stopping provision of preventive service remain the same 
• For preventive medications, the recommended dosing remains unchanged 
Increased intensity (at least one criterion must apply)  
• Recommendations apply to larger population 
• Recommended screening or counseling intervals decrease (i.e. more frequent) 
• Recommended ages for starting or stopping provision of preventive service become broader 
• For preventive medications, the recommended dosing is increased 
Decreased intensity (at least one criterion must apply)  
• Recommendations apply to smaller population 
• Recommended screening or counseling intervals increase (i.e. less frequent 
• Recommended ages for starting or stopping provision of preventive service become narrower 
• For preventive medications, the recommended dosing is decreased 
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Tracking dropped and new “D” recommendations against the use of preventive services 
  The Task Force sometimes chooses not to update a previously issued individual 
recommendation for a specific intervention or subpopulation.  Occasionally, a previously issued 
negative recommendation is not updated.  The 2016 recommendation statement on breast cancer 
screening, for instance, did not issue a recommendation for teaching women how to perform the 
breast self-examination.35 In the previously issued 2009 recommendation statement on breast 
cancer screening, this intervention received a “D” recommedation.36  I reviewed all 
recommendation statements to identify other dropped “D” recommendations. For comparison 
purposes, I also reviewed all recommendation statements to identify new “D” recommendations 





















Summary of active USPSTF recommendations 
  As of June 1, 2017, the USPSTF lists 98 topics on its website, including 84 active 
topics.30  For each active topic, the Task Force has published one or more individual 
recommendations with associated letter grades. The currently active topics cover 132 unique 
recommendations.  The number and proportion of active recommendations stratified by grade is 
depicted in Table 6.  Notably, “I” statements constitute the greatest proportion and “C” 
recommendations constitute the smallest proportion of letter grades assigned to individual 
recommendations.  Approximately twice as many recommendations endorse the routine use of a 
preventive services (“A” or “B” recommendations) compared to those that recommend against 
the routine use of a service (“D” recommendations). 
  
  In order for the National Guidelines Clearinghouse to accept a submitted clinical practice 
guideline, the guideline must have been developed, reviewed, or revised within the past five 
years.34  A total of 98 currently active recommendations have been issued within the past five 
years covering 63 topics (75% of active topics).  Similar to the entire set of active 
Table 6. Number and proportion of active recommendations by grade (as of June 1, 2017) 
Grade 
All active recommendations 
Active recommendations issued between  
June 1, 2012 and June 1, 2017 
Number Proportion Number Proportion 
A 14 10.6% 8 8.2% 
B 33 24.8% 27 27.6% 
A or B 47 35.6% 35 35.7% 
C 7 5.3% 6 6.1% 
D 25 18.9% 13 13.3% 
I 53 40.2% 44 44.9% 
Total 132 n/a 98 n/a 
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recommendations, positive (“A” or “B”) recommendations outnumber negative 
recommendations, while “I” statements are the most common.  
  Of all current recommendations statements issued on active topics, half include at least 
one positive recommendation; whereas, less than a quarter include at least one negative 
recommendation (Table 7). Few recommendation statements include a “C” recommendation, 
while a majority include at least one “I” statement.   
Table 7. Number and proportion of active recommendation statements with 
individual recommendations of certain grades (as of June 1, 2017); total 
number of active topics = 84 





At least one “A” recommendation 12 14.3% 
At least one “B” recommendation 31 36.9% 
At least one “A” or “B” recommendation 42 50.0% 
At least one “C” recommendation 7 8.3% 
At least one “D” recommendation 20 23.8% 
At least one “I” statement 45 53.6% 
 
Allocation of USPSTF recommendation grades over time 
  The number of individual recommendations issued by year and grade is depicted is 
Figure 3. Since 2001, the USPSTF has issued 164 recommendation statements covering 288 
individual recommendations.  On a year to year basis, significant heterogeneity exists in both the 
total number of issued recommendations and the proportion of recommendations issued by grade 
(for a detailed breakdown, see Appendix B, Table B5).  In 2010, for instance, the Task Force 



















Figure 3. Number of individual USPSTF recommendations issued by letter grade per year (as of 
June 1, 2017).
 
    When recommendations are grouped into three time periods based on publication date, 
trends in the allocation of recommendation grades can be observed (Figure 4).  While the 
proportion of all positive recommendations published during each of these time periods has 
remained relatively stable, the proportion of “B” recommendations has increased relative to 
recommendations published in earlier time periods.  Conversely, the proportions of published 
“A” recommendations and “D” recommendations have decreased.  Across time periods, 
relatively few “C” recommendations have been issued.  Finally, since 2013, the proportion of 
issued “I” statements has increased compared to previous time periods.  These trends are 
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either direction (see Appendix B, Table B6).  Including 2012 in the most recent time period, 
however, substantially decreases the observed decline in the proportion of issued “D” 
recommendations compared to earlier time periods. This finding can be explained by the high 






























A B A or B C D I 
2001-2005 16 (15.8%) 18 (17.8%) 34 (33.7%) 6 (5.9%) 24 (23.8%) 37 (36.6%) 101 
2006-2012 18 (18.4%) 18 (18.4%) 36 (36.7%) 7 (7.1%) 22 (22.4%) 33 (33.7%) 98 
2013-2017 8 (9.0%) 26 (29.2%) 34 (38.2%) 5 (5.6%) 9 (10.1%) 41 (46.1%) 89 
Total 42 (14.6%) 62 (21.5%) 104 (36.1%) 18 (6.3%) 55 (19.1%) 111 (38.5%) 288 
Figure 4.  The number and proportion of recommendations issued by grade stratified into three 
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Allocation of USPSTF recommendation grades by topic status:  new versus updated 
   Of the 164 recommendation statements published by the Task Force since 2001, 142 
statements issued updated recommendations for previously evaluated topics.  The remaining 22 
statements issued recommendations for new topics.  While a majority of all recommendation 
statements issued a single recommendation for the evaluated topic, 43% issued more than one 
recommendation (see Appendix B, Figure B2).  A majority of recommendation statements 
included at least one positive recommendation (Table 8). A slightly larger majority of 
recommendation statements included at least one “I” statement. Smaller proportions of 
recommendation statements included at least one “D” or at least one “C” recommendation. 
Notably, greater proportions of recommendation statements issued on new topics included at 
least one “D” recommendation or at least one “I” statement compared to recommendation 
statements for updated topics.  
 
Allocation of USPSTF recommendation grades by topic over time 
  When grouping recommendation statements into three time periods based on publication 
date, similar findings can be observed compared to those seen for all individual 
recommendations (Figure 5).  Since 2013, a greater proportion of published recommendation 
statements have included at least one “B” recommendation compared to earlier time periods.  
Smaller proportions of recommendation statements have included at least one “A” or at least one 
Table 8. Number and proportion of recommendation statements containing at least one 
individual recommendation of particular grades. Data tabulated for all recommendation 




Contains at least one recommendation of the following grades: 
A B A or B C D I 
Updated 142 34 (23.9%) 53 (37.3%) 81 (57.0%) 17 (12.0%) 38 (26.8%) 77 (54.2%) 
New 22 0 (0.0%) 4 (18.2%) 4 (18.2%) 0 (0.0%) 9 (40.9%) 17 (77.3%) 
Total 164 34 (20.7%) 57 (34.8%) 85 (51.8%) 17 (10.4%) 47 (28.7%) 94 (57.3%) 
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“D” recommendation.  For all three time periods, a majority of published recommendation 
statements have included at least one “I” statement.  A small uptick in this proportion has 
occurred over the past several years.  Adjusting the boundaries of the time periods by one to two 
























Contains at least one recommendation of the following grades: 
Total 
A B A or B C D I 
2001-2005 13 (24.5%) 17 (32.1%) 26 (49.1%) 5 (9.4%) 21 (39.6%) 33 (62.3%) 53 
2006-2012 15 (27.3%) 16 (29.1%) 29 (52.7%) 7 (12.7%) 17 (30.9%) 28 (50.9%) 55 
2013-2017 6 (10.7%) 24 (42.9%) 30 (53.6%) 5 (8.9%) 9 (16.1%) 33 (58.9%) 56 
Total 34 (20.7%) 57 (34.8%) 85 (51.8%) 17 (10.4%) 47 (28.7%) 94 (57.3%) 164 
Figure 5.  The number and proportion of recommendation statements containing at least one 
individual recommendation of a particular grade stratified into three time periods. Data for all 
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Point-based assessment of the directionality of topic updates over time 
  Of the 142 recommendation statements issued on updated topics since 2001, a neutral 
directionality score was the most commonly assigned score (Table 9) using both point-based 
assessment methods.  A larger proportion of topic updates were assigned a positive directionality 
score compared to a negative score using method 1.  For method 2, however, similar proportions 
of topic updates were assigned positive and negative directionality scores.  
Table 9. Number and proportion of topic updates by directionality assessed using two point-
based assessment methods; n = 142. Data tabulated for all recommendation statements issued 
on updated topics from 2001 to 2017 (as of June 1, 2017). 
 
Point-based directionality score 
Positive Neutral Negative 
Method 1 45 (31.7%) 63 (44.4%) 34 (23.9%) 
Method 2 31 (21.8%) 81 (57.0%) 30 (21.1%) 
   
  Grouping topic updates into three time periods reveals trends in the directionality topic 
updates over time using both point-based assessment methods (Figure 6). The proportion of topic 
updates assigned positive directionality scores is greater for updates issued from 2013 to 2017 
compared to those issued from 2006 to 2012. Conversely, the proportion of topics updates 
assigned negative directionality scores is smaller.  The proportion of topic updates issued neutral 
scores is greater for updates issued from 2006 to 2012 compared to updates issued from 2001 to 
2005, but is similar when comparing the most recent time period to 2006 to 2012.  Adjusting the 
boundaries of the time periods by one to two years in either direction does not affect these 






























Point-based directionality score 
Total Method 1 Method 2 
Positive Neutral Negative Positive Neutral Negative 
2001-2005 14 (29.8%) 18 (38.3%) 15 (31.9%) 11 (23.4%) 22 (46.8%) 14 (29.8%) 47 
2006-2012 11 (23.9%) 22 (47.8%) 13 (28.3%) 6 (13.0%) 28 (60.9%) 12 (26.1%) 46 
2013-2017 20 (40.8%) 23 (46.9%) 6 (12.2%) 14 (28.6%) 31 (63.3%) 4 (8.2%) 49 
Total 45 (31.7%) 63 (44.4%) 34 (23.9%) 31 (21.8%) 81 (57.0%) 30 (21.1%) 142 
Figure 6. The number and proportion of topic updates assigned positive, neutral, and negative 
directionality scores using two point-based assessment methods stratified into three time periods. 
Data included for all recommendations statements issued on updated topics from 2001 to 2017 
(as of June 1, 2017). 
 
Classification-based assessment of the directionality of topic updates over time 
  A letter score of neutral directionality was assigned to a majority of the 142 topic updates 
issued from 2001 to 2017 (Table 10).  Of these, a letter score of “positive to equally as positive” 
was most common.  Smaller proportions of updated topics were assigned letter scores of positive 
directionality and negative directionality. Of the topic updates assigned letter scores of positive 
directionality, a majority (22 of 27, 81.5%) included a recommendation in favor of routinely 
offering a preventive service (letter scores of “positive to more strongly positive”, “neutral to 





















Table 10. Number and proportion of topic updates by letter score and letter score 
directionality; n = 142. Data tabulated for all recommendation statements issued on 








Positive to more strongly positive 6 (4.2%) 
Positive 27 (19.0%) 
Neutral to positive 14 (9.9%) 
Negative to positive 2 (1.4%) 
Negative to neutral 5 (3.5%) 
Negative to less strongly negative 0 (0.0%) 
Positive to equally as positive 44 (31.0%) 
Neutral 85 (59.9%) Neutral to neutral 27 (19.0%) 
Negative to equally as negative 14 (9.9%) 
Positive to less strongly positive 15 (10.6%) 
Negative 30 (21.1%) 
Positive to neutral 5 (3.5%) 
Positive to negative 2 (1.4%) 
Neutral to negative 5 (3.5%) 
Negative to more strongly negative 3 (2.1%) 
 
  When topics updates are grouped into three periods based on the directionality of their 
assigned letter scores, similar findings result in comparison to those seen using the point-based 
methods (Figure 7).  For topics updates issued from 2013 to 2017, the proportion assigned a 
letter score of positive directionality is slightly greater compared to topic updates issued from 
2006 to 2012, but slightly smaller compared to topic updates issued from 2001 to 2005.  The 
proportion of topic updates assigned a letter score of negative directionality has decreased across 
each of these periods, while the proportion of topic updates assigned a letter score of neutral 





































Figure 7. The number and proportion of topic updates issued letter scores of positive, neutral, 
and negative directionality. Data included for all recommendations statements issued on updated 
topics from 2001 to 2017 (as of June 1, 2017). 
 
  A total of 65 (45.8%) topic updates received a variant of a “positive to positive” letter 
score which made them eligible for the additional assignment of an intensity score. Overall a 
majority of these updates received an intensity score of “same intensity,” while smaller 
proportions received scores of “increased intensity” and “decreased intensity” (Figure 8).   
Notably, over the most recent time period (2013 to 2017), a greater proportion of updates 
received a score of “increased intensity” and a smaller proportion received a score of “decreased 
intensity” compared to the previous time periods.  The proportion of topic updates receiving a 
score of “same intensity” increased across time periods.  Varying the time periods by one to two 
Time 
period 
Directionality of Letter Score 
Total 
Positive Neutral Negative 
2001-2005 11 (23.4%) 23 (48.9%) 13 (27.7%) 47 
2006-2012 6 (13.0%) 28 (60.9%) 12 (26.1%) 46 
2013-2017 10 (20.4%) 34 (69.4%) 5 (10.2%) 49 
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years in either direction preserves the trends observed for letter scores and intensity scores (see 


























Figure 8. The number and proportion of topic updates issued for each of the possible intensity 
scores stratified in three time periods from 2001 to 2017 (as of June 1, 2017). 
 
Dropped and new “D” recommendations against the use of preventive services 
  The Task Force chose not to update a “D” recommendation for a previously evaluated 
intervention or population on eight identified occasions (Appendix B, Table B11).  A majority of 
these dropped “D” recommendations occurred in the past several years (6 of 8 since 2013). They 
include instances when the Task Force dropped a recommendation against the use of a 
preventive service in a low-risk population37–40, a recommendation against the use of a service in 





Increased Same Decreased 
2001-2005 2 (11.1%) 11 (61.1%) 5 (27.8%) 18 
2006-2012 1 (4.2%) 17 (70.8%) 6 (25.0%) 24 
2013-2017 5 (21.7%) 17 (73.9%) 1 (4.3%) 23 












intervention.35     
  On 14 occasions, the Task Force issued a new “D” recommendation for a previously 
unevaluated intervention or population (Appendix B, Table B12). A majority of these 
recommendations were issued for new topics (9 of 14).  Only one of these recommendations has 
been issued since 2013.  The number of new and dropped “D” recommendations stratified by 










Table 11. Number of dropped “D” recommendations and new “D” recommendations 





Number of new “D” recommendations  
(intervention or population not previously evaluated) 
New topics Updated topics All topics 
2001-2005 2 5 3 8 
2006-2012 0 3 2 5 
2013-2017 6 1 0 1 





Primary study findings 
   In this study, I sought to address the recent allegation that the Task Force has become 
increasingly generous in issuing recommendations in favor of the use of preventive services.7 If 
true, I hypothesized that this change could have an observable effect on the allocation of 
individual recommendation grades, the directionality of topic updates, or both.  The results of 
this study, however, indicate that the proportion of recommendations assigned positive letter 
grades has only slightly increased over time.  Instead, the proportion of negative 
recommendations issued over the past several years has substantially decreased, while the 
proportion of “I” statements has increased.  Furthermore, the study findings consistently indicate 
that negative changes in the overall set of recommendations issued for updated topics have 
become less common over time, while neutral changes (no change in the updated set of 
recommendations for a topic) have become more common.  More recently, positive changes 
have become increasingly common. Each of these main findings is discussed in greater detail 
below.  
 
Changes in the allocation of recommendation grades over time 
   If the Task Force is increasingly promoting preventive services, such a shift should result 
in a greater proportion of recommendations issued positive letter grades. Instead, the overall 
proportion of recommendations issued “A” or “B” letter grades has only slightly increased over 
time.  Furthermore, the proportion of recommendations issued “A” letter grades has decreased.  
Similar trends have occurred for the proportions of recommendation statements including at least 
one “A” or “B” recommendation. Taken together, these findings indicate that the proportion of 
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recommendations issued positive letter grades has not substantially increased over time, and 
conversely, that “A” recommendations have become less common. 
 While the proportion of positive recommendations issued by the Task Force has remained 
relatively stable over time, both the proportion of recommendations issued “D” letter grades and 
the proportion of recommendation statements including at least one “D” recommendation have 
markedly decreased.  These observed reductions have at least three potential contributors.  First, 
the number of new topics including a “D” recommendation has decreased over time. Second, the 
Task Force has increasingly chosen not to update several “D” recommendations for previously 
evaluated interventions and/or populations.  Finally, the observed increase in “I” statements 
could be reflective of an increase in the evidence threshold necessary for issuing “D” 
recommendations.  
 
Changes in the directionality of topic updates over time  
     An increase in the promotion of preventive services could result from changes in  
recommendations made when updating previously evaluated topics. In this study, both a point-
based and a classification-based method were used to measure the overall directionality of these 
changes for updated topics.  The point-based method considered all recommendations issued on 
a topic, regardless of whether they covered interventions or populations evaluated by both the 
updated and previously issued sets of recommendations.  The classification-based system, on the 
other hand, only considered recommendations for interventions and populations covered by both 
the prior and updated set of recommendation.  Despite this difference, both methods yielded 
similar results. First, regardless of how the directionality of topic updates is assessed, neutral 
changes (no change in the updated set of recommendations for a topic) have become 
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progressively more common. Second, there has been a recent increase in positive changes and a 
sustained decrease in negative changes made when issuing updated recommendations. While 
these findings could be explained by changes in evidence for evaluated services, they could also 
indicate that the Task Force has become less hesitant to promote the use of preventive services 
and/or more reluctant to discourage the use of services. 
 
Limitations 
  The small number of recommendations issued by the Task Force on an annual basis 
limits the ability to draw strong inferences about the presence or absence of trends in the 
allocation letter grades and the directionality of topic updates over time. Because of the 
substantial heterogeneity in both the total number of recommendations and proportion of 
recommendations assigned specific letter grades in any individual year, such trends are only 
observable when grouping recommendations into time periods of longer duration. While most of 
the key findings of this study are preserved when adjusting the boundaries of the selected time 
periods, the possibility that some of these findings could be explained by random variability in 
the issuance of recommendations cannot be excluded.  Despite this limitation, the consistency of 
the findings serves as a strength of the study.  Furthermore, since all issued recommendations are 
included in the analyses, there is no uncertainty in the values reported in the study.  
   Each of the methods used to evaluate the directionality of topic updates also has distinct 
limitations. The first point-based method for assessing the directionality of topic updates 
provides insight into how the average recommendation letter grade issued for individual 
recommendations for a topic changes when the recommendations issued on a topic are updated. 
The second method provides insight into the how the quantity of individual recommendations in 
35 
 
favor and against the use of preventive services for a topic change when the recommendations on 
the topic are updated.  Any updated individual recommendation, however, may differ in the 
specific populations or interventions it covers compared to the previously issued 
recommendation(s). The point-based methods for assessing the directionality of topic updates do 
not take these potential changes into account.  As such, these scores may not always reflect how 
the breadth of preventive services recommended by the Task Force on a topic change.  
 In contrast, the classification-based system for evaluating topic updates only considers 
recommendations for interventions and populations covered by both the prior and updated set of 
recommendations on the topic.  The letter score reflects changes in the strength of 
recommendations for interventions in populations covered by both sets of recommendations, 
while the intensity score reflects changes in the breadth of interventions issued positive 
recommendations. Unlike the point-based methods for measuring the directionality of topic 
updates, however, recommendations for interventions or populations evaluated only in the 
updated or previous set of recommendations on a topic do not factor into the assignment of these 
scores.  Thus, the point-based and classification-based methods for evaluating topic updates are 
complementary, each offering a different characterization of how the set of recommendations 
issued on a topic change when updated.  
  Finally, only a single researcher (GT) assigned letter scores and intensity scores to topic 
updates. The inter-rater reliability of these scores was not assessed.  A second researcher (RH), 
however, evaluated a selected subset of topic updates, with differences in the assignment of 




Possible explanations of the primary study findings and their implications 
  Several possible factors could have contributed to the longitudinal changes in the 
issuance of Task Force recommendations observed in this study. These potential factors include 
changes in evidence for evaluated services, changes in the methodology for assigning 
recommendations, political pressures, the link between coverage policy and recommendations, 
and changes in the thresholds used to delineate recommendation grades.  As opposed to one 
single factor, some combination of these factors (or others) likely explain the findings of this 
study. The possible influence of each suggested factor is discussed more fully below.  
   Changes in evidence.  A change in the letter grade for a previously issued 
recommendation may result from a change in the evidence base used to assess the certainty and 
magnitude of net benefit of the evaluated preventive service.  Changes in evidence may also 
make the issuance of a recommendation less relevant or may justify the issuance of new 
recommendation for a specific subpopulation or intervention.  Across time, several 
uncontentious changes have been made to recommendations based on new evidence widely 
deemed sufficient to justify the changes.  On other occasions, however, recommendation changes 
have faced criticism for relying on new evidence considered insufficient to merit such changes.  
These criticisms raise the question of whether other factors, beyond changing evidence, could be 
responsible for the broad changes in the allocation of recommendation grades and the 
directionality of topic updates suggested by this study.  
  Methodological changes. The methodology used by the Task Force to evaluate evidence, 
its process for assigning recommendation letter grades, and the standard language associated 
with letter grades have all significantly evolved over time.  Changes in any of one these domains 
could have broadly affected the issuance of recommendations and contributed to the findings of 
37 
 
this study.  Across time, however, the fundamental approach used to develop recommendations 
has remained stable.  The Task Force assesses both the sufficiency of available evidence and the 
balance of harms and benefits for a preventive service in making a recommendation for or 
against its use.  Thus, while the findings of this study could, in part, be explained by longitudinal 
changes in the methodology used by the Task Force to issue recommendations, other factors are 
also likely to be at play. 
 Political pressures.  As amended by the PPACA42, the Public Health Service Act asserts 
that “all members of the Task Force …, and any recommendations made by such members, shall 
be independent and, to the extent practicable, not subject to political pressure.”43 Despite this 
requisite, the Task Force has not always been able to avoid the political spotlight.  The most 
prominent example of Task Force recommendations entering the political realm occurred during 
the height of health reform deliberations in 2009.  In November of that year, the Task Force 
published an updated set of recommendations on breast cancer screening, including a 
controversial “C” recommendation “against routine screening mammography” in women aged 
40 to 49 years.36  While the previously issued recommendation had “made a similar point in 
different words,” the media portrayed this change as a new recommendation against 
mammography for all women in this age group.44,45  The Task Force quickly faced a bevy of 
criticism, including public calls for its dissolution.46  In December 2009, Senator David Vitter 
(R-LA) proposed an amendment to the Senate health care bill which required health care 
legislation and any other provision of law to refer to the previously issued 2002 
recommendations on breast cancer screening.47 The Senate immediately accepted the amendment 
by unanimous consent agreement.  A few days later, the Task Force voted to update the language 
of its “C” recommendation to clarify its original intent by omitting the widely misinterpreted first 
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sentence advocating against “routine” screening.36  Nevertheless, the political fallout generated 
by this recommendation has had lasting effects. To this day, Congress continues to mandate that 
all provisions of the law refer to the 2002 breast cancer screening guidelines.48  
  In the immediate aftermath of this controversy, the pace of recommendations issued by 
the Task Force dramatically dropped.  In 2010, the Task Force issued only a single 
recommendation, a politically placatory “B” recommendation in favor of screening children for 
obesity.  Late in the year, the Task Force cancelled a meeting scheduled to occur immediately 
prior to the mid-term elections. At the meeting, the Task Force had planned to vote on the 
controversial topic of screening for prostate cancer.49  This cancellation led a medical officer at 
the Agency for Healthcare Research and Quality, which provides support services to the Task 
Force, to resign in protest and declare that “politics trumped science.”50  
  The Task Force waited until May 2012 to publish its updated recommendations on 
prostate cancer screening, which included an expanded recommendation against PSA-based 
screening for prostate cancer in all men.25  These recommendations resulted in significant public 
outcry similar, although more mooted in intensity, to the reception the 2009 breast cancer 
screening recommendations received. As a former chair of the Task Force, Ned Calonge, has 
observed, “I think anytime you use science to kind of fundamentally change what people are 
used to, I think it’s a difficult thing to grapple with.”51 Clearly, the prospect of negative attention 
has affected the timeline for the release of certain recommendations. This study additionally 
suggests that the Task Force has become more reluctant to issue negative recommendations and 
make changes to recommendations that result in the decreased promotion of preventive services.  
Could the fear of public resistance resulting in political repercussions, at least on a subconscious 
level, be related to these findings as well?  
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  Coverage linkages. In 2010, the Patient Protection and Affordable Care Act (PPACA) 
established the requirement for health insurers to provide first-dollar coverage for services with 
“A” or “B” recommendations.42  Some commentators argue that this linkage may encourage the 
Task Force to increasingly issue positive recommendations.52,53  Steven Woolf (a former Task 
Force member) and Doug Campos-Outcalt (a former liaison between the Task Force and the 
American Academy of Family Physicians), for instance, suggest that this linkage exerts “a 
subliminal pressure [on Task Force members] to reinterpret the evidence knowing the 
ramifications, and to lower threshold for A and B recommendations” and that it “puts [the] 
analytic rigor [of the Task Force] at risk by preventing members from concentrating on the 
science.”52    
   If the linkage between Task Force recommendations and coverage policies has had a 
substantial influence on the issuance of recommendations, one or more potential downstream 
manifestations might be observable.  First, such influence could have led to an increase in the 
overall proportion of “A” and “B” recommendations issued by the Task Force. The results of this 
study, however, suggest that the overall proportion of positive recommendations has, at most, 
only slightly increased over the past several years. Second, increased pressure to issue positive 
recommendations could have caused updated recommendations to move in an increasingly 
positive direction. As discussed earlier, this study provides some evidence to support the 
existence of this phenomenon, although its magnitude may be small. Finally, because of the 
coverage implications associated with rescinding currently existing “A” and “B” 
recommendations, the pressure against making such changes could have caused fewer updated 
recommendations to move in a negative direction.  The smaller proportion of recent topic 
updates assigned negative directionality scores may, in part, be related to this pressure. 
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  Shifting thresholds. In issuing a recommendation letter grade, the Task Force separately 
considers both the certainty and the magnitude of net benefit for an intervention in a specific 
population.  The USPSTF procedure manual defines the certainty of the magnitude of net benefit 
as “the width of the conceptual confidence interval given by the evidence to estimate the 
magnitude of net benefit.”43 Thus, the assessment of certainty is not quantitative, but instead 
requires the Task Force to judge how well the available evidence for a preventive service fits 
together across an analytic framework linking the population at risk to health outcomes.   
  As with its assessment of certainty, the assessment of the magnitude of net benefit 
requires judgement, especially because the outcomes used to measure benefits and harms are 
often different and/or measured over different time frames. Weighing the relative value of the 
considered outcomes depends on the evaluator and may not always be reflective of how an 
average patient would value these outcomes. Additionally, the absence of clearly defined 
thresholds for delineating different levels of net benefit (zero/negative, small, moderate, 
substantial) incorporates further judgement into the assignment of letter grades. 
 Since USPSTF members serve on a rotating basis, longitudinal differences in the 
membership of task force could influence the thresholds used to determine both the level of 
certainty and the level of magnitude of net benefit of evaluated services.  Other pressures, such 
as those discussed above, may have a further subconscious effect on these thresholds.  If the 
thresholds for assigning recommendation grades are changing, shifts in the allocation of 
recommendation grades and the directionality of topic updates could be observable.  As 
discussed above, several findings of this study suggest the presence of such shifts. The decrease 
in proportion of “D” recommendations issued over the past several years, for instance, could be 
reflective of an increase in the threshold for a preventive service to be judged as having moderate 
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certainty of zero to negative net benefit.   
  In its draft of the updated recommendations for prostate cancer screening, the Task Force 
proposes a change in the “D” recommendation against prostate cancer screening in men ages 55 
to 69 to a “C” recommendation.28 The Task Force advocates for this change on the basis of 
“additional evidence that increased the … certainty about the reductions in risk of dying of 
prostate cancer and risk of metastatic disease” as well as on “new evidence about and increased 
use of active surveillance of low-risk prostate cancer, which may reduce the risk of subsequent 
harms from screening.”  Could this proposed recommendation change, however, also be 
reflective of a decreasing threshold needed for a preventive service to be judged as having 
“small” net benefit? 
 
Suggestions for improvement  
   The Task Force needs to be aware of trends in the issuance of its recommendations, 
particularly because they may in part be reflective of influences beyond changes in evidence for 
the services it evaluates.  More broadly, all standing committees that issue clinical guidelines 
could benefit from monitoring for such trends. Doing so would serve as the first step for 
identifying pressures that may be influencing the overall allocation of recommendation grades 
and the propensity for updated recommendations to change in a particular direction.   
Second, the possibility that the Task Force may be shying away from issuing 
recommendations against the use preventive services is concerning.  Since its inception, the Task 
Force has intended to serve as an authority not only on the preventive services that ought to be 
routinely provided to patients, but also on those that ought not to be routinely provided.  Just as 
the issuance of positive recommendations can bring attention to the underuse of services with net 
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benefit, negative recommendations can discourage the overuse of services with zero to negative 
net benefit.  While groups such as Choosing Wisely have increased awareness of medical 
overuse, they do not consistently offer recommendations grounded solidly in evidence.  Thus, 
there exists a need for a group to provide such recommendations.  Historically, the Task Force 
has filled this role.  On several occasions, it has issued recommendations against the routine use 
of preventive services in the face of resistance from the general public and other stakeholders. 
The Task Force needs to continue its historical legacy of providing this vital guidance to 
clinicians when the science supports doing so.  
  Third, determining the level of certainty of the overall evidence and the level net benefit 
for an evaluated preventive service requires judgement on the part of Task Force.  The USPSTF 
Procedure Manual provides definitions and a set of criteria for each level of certainty.54  The 
manual does not specify, however, specific criteria for differentiating levels of net benefit.  By 
providing clear definitions and a set of criteria for each level of net benefit, the Task Force could 
decrease the potential for shifting interpretations of these levels to influence the overall issuance 
of its recommendations. 
  Finally, the Task Force must re-evaluate its method for communicating recommendation 
grade changes.  Currently, the Task Force discusses how updated recommendations compare to 
the previous recommendations for a given topic in a section located near the end of each 
recommendation statement.  A clear statement underscoring the evidence that merits each 
change, however, is not always provided.  Furthermore, the Task Force does not always clearly 
articulate its reasoning for dropping recommendations for previously evaluated populations or 
services.  By more clearly communicating its rationale for making these changes, the Task Force 






  The Task Force has developed a reputation for basing its recommendations on rigorous 
assessments of evidence. Its commitment to using evidence to drive the development of its 
recommendations, however, has occasionally led to the issuance of recommendations in 
opposition to current clinical practice or popular thinking.  In the past, criticisms of the Task 
Force have often focused on the perception that its evidence threshold is greater than necessary 
for issuing recommendations for or against the use of preventive services.55 Recently, however, 
the Task Force has come under fire for issuing several recommendations deemed overly 
generous in promoting the use of preventive services.7  This study, however, did not find 
evidence that the overall allocation of positive recommendations has markedly increased over 
time.  Instead, the Task appears to be issuing fewer “D” recommendations against the routine use 
of preventive services and decreasingly making changes to recommendations that result in the 
reduced promotion of services.  Beyond changes in the evidence for evaluated services, other 
factors such as changes in the methodology for assigning recommendations, political pressures, 
the link between coverage policy and recommendations, and changes in the thresholds used to 
delineate recommendation grades may explain these findings.   Further research is needed to 
evaluate the extent to which each of these factors has contributed to the trends observed in this 
study. In the interim, continuously monitoring for trends in the issuance of its recommendations 
may help the Task Force identify and respond to possible external pressures that may be 




APPENDIX A:  Additional methodological considerations and illustrative examples of the 
assignment of letter scores and intensity scores 
 
 
Special considerations for recommendations published in the second edition Guide  
 In 1996, the second Task Force published the second edition of the Guide which included 
recommendations for 70 different preventive care topics.31 The current practice of publishing 
recommendation statements for individual topics on a continual basis was not established until 
the third Task Force began issuing recommendations in 2001.  Each chapter in the second edition 
of the Guide corresponds to a preventive care topic and begins with a brief summary of the 
overall recommendations for the topic.  Further details, including letter grades for individual 
recommendations within a topic, are provided in a “Clinical Intervention” section located at the 
end of each chapter.  Unlike current recommendation statements which include a “Summary of 
Recommendations” section that clearly delineates each specific recommendation using standard 
language including its associated recommendation grade, the specific recommendations and 
associated letter grades for topics in the second edition of the Guide are not always clearly 
denoted within the chapter written on a given topic.  An appendix to the Guide, however, 
provides tables of ratings for all of the examined topics and clearly depicts the letter grades 
associated with each preventive intervention evaluated for a given topic.33  When comparing 
recommendations for preventives care topics issued in the second edition of Guide with updated 
recommendations, these tables served as the basis for identifying the individual 
recommendations made by the second Task Force for each topic.  The specific chapter for each 
topic provided the associated recommendation language and additional context for interpreting 
each individual recommendation. 
 For counseling interventions, the second Task Force considered both the evidence that 
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changing personal behavior could improve health outcomes and the evidence that clinicians 
could influence behaviors through counseling.56 Separate recommendation letter grades were 
issued for specific counseling interventions based on the evidence of the effectiveness of 
counseling and on the evidence linking behaviors with health outcomes.  The authors noted that 
the effects of counseling for many specific behaviors had never been studied.56  Accordingly, the 
second edition of the Guide stratified specific recommendations for counseling topics into two 
categories related to the “Efficacy of Risk Reduction” and the “Effectiveness of Counseling.”33  
In some cases, available evidence regarding the effectiveness of counseling patients on certain 
health behaviors was insufficient to issue a positive recommendation; however, a positive overall 
recommendation for a counseling intervention was made on the basis of strong evidence for the 
association between a behavior and health outcome.  In these instances, the Task Force argued 
that advising patients about health-related behaviors is generally safe and inexpensive and could 
result small behavioral changes leading to important health benefits at a population level.56  The 
Task Force, for instance, recommended counseling patients to incorporate regular physical 
activity into their daily routines on the basis of the proven benefits of regular physical activity in 
preventing coronary heart disease, hypertension, obesity, and diabetes, even though they 
concluded that the effect of counseling in promoting physical activity had not been well 
established.57   
    The third Task Force made several significant modifications to the methodology that is 
currently used to issue guidelines.32  For counseling interventions, the practice of providing 
separate letter grades related to the efficacy of risk reduction associated with specific health 
behaviors and to the corresponding effectiveness of counseling to modify these behaviors was 
discontinued.  Instead, recommendations for counseling interventions are now based on an 
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evaluation the overall certainty of evidence of net benefit and its magnitude across an analytic 
framework which includes linkages between the counseling intervention, behavioral changes, 
and patient-centered health outcomes (such as reductions in morbidity and mortality).32,58  To 
issue a letter grade for or against routinely offering an intervention, the current grading system 
requires evidence of moderate certainty that directly or indirectly links a preventive service with 
health outcomes.   
  Because the letter grades for counseling interventions issued in the second edition of the 
Guide apply to specific linkages within an analytic framework, comparing them to updated 
recommendations developed using the current methodology is challenging.  Under the current 
methodology, a counseling intervention without sufficient evidence demonstrating either a direct 
link between the intervention and health outcomes or an indirect link via its effect on eliciting 
behavioral change would likely be issued an “I” grade.  Notably, in the second edition of the 
Guide, the strength of the recommendations related to the effectiveness of counseling 
interventions never exceeded the strength of the recommendations related to the efficacy of risk 
reduction for corresponding health behaviors.  For several topics, the Task Force issued a 
positive recommendation related to efficacy of risk reduction for a health behavior, but 
concluded that insufficient evidence existed to issue a recommendation for or against the 
effectiveness of counseling to modify the behavior.  These interventions would likely have been 
given “I” letter grades had the current Task Force methodology been applied. In 2002, for 
instance, the USPSTF issued an “I” statement for behavioral counseling in primary care settings 
to promote physical activity after finding insufficient evidence to determine whether counseling 
patients leads to sustained increases in physical activity.59 Concurrently, the Task Force 
recognized that substantial evidence supported the efficacy of physical activity in reducing 
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chronic disease morbidity and mortality. Even though the general conclusions regarding the 
effectiveness of counseling and the efficacy of physical activity in reducing disease risk 
remained unchanged from previous review of the topic conducted by the second Task Force, the 
third Task Force dropped the positive recommendation for behavioral counseling to promote 
physical activity due to the lack of evidence demonstrating the effectiveness of counseling.59  A 
similar pattern was observed for other recommendations related to counseling interventions 
updated from recommendations made by the second Task Force including those for counseling 
patients to avoid alcohol-related motor vehicle occupant injuries60 and counseling unselected 
patients to promote a healthy diet.61  Given the differences in the assignment of 
recommendations to counseling interventions made by the second Task Force, only the 
recommendations (and associated letter grades) regarding the effectiveness of counseling were 
considered when making comparisons with updated recommendations that utilized the current 
methodology for assigning recommendation letter grades.  These letter grades likely approximate 
the letter grades the Task Force would have assigned to counseling interventions had the current 
methodology been applied at the time.  
    An exception to this to this rule was made in the comparison of the 2012 
recommendations for the prevention of falls in older adults to the corresponding 
recommendations included in the second edition of the Guide.  In 2012, the USPSTF assessed 
the evidence for the effectiveness of multifactorial clinical assessments, clinical management 
(including vitamin D supplementation and hip protectors), clinical education or behavioral 
counseling, home hazard modification, and exercise or physical therapy in reducing falls and the 
negative health outcomes associated with falls in community-dwelling older adults.62 The Task 
Force issued two recommendations for elderly community-dwelling adults including a “B” 
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recommendation for providing exercise or physical therapy and vitamin D supplementation for 
individuals at increased risk for falls, and a “C” recommendation for routinely performing in-
depth multifactorial risk assessments with comprehensive management of identified risks.  
Specific recommendations were not issued for several other preventive interventions to reduce 
falls assessed by the Task Force including vision correction, education or counseling, home 
hazard modification, and others.  In the recommendation statement, however, the Task Force did 
briefly note that these interventions lacked sufficient evidence for or against their use in the 
prevention of falls in community-dwelling older adults.62 In the second edition of the Guide, 
recommendations regarding preventive interventions for reducing falls in elderly adults were 
addressed in the broader chapter on counseling to prevent household and recreational injuries.63 
In this chapter, several interventions related to the prevention of falls in elderly adults, but 
unrelated to counseling, were assigned recommendation letter grades on the basis evidence of 
their efficacy in reducing the risk of falls.  Because the updated 2012 recommendations also 
assessed non-counseling interventions for preventing falls, these recommendations were included 
in the comparison of the updated and historical recommendations for the prevention of falls in 
elderly adults. 
   A second exception was made in the comparison of the 2004 recommendations for the 
prevention of dental caries in preschool children to corresponding recommendations in the 
second edition of the Guide.  In 2004, the USPSTF issued a “B” recommendation for the 
prescription of fluoride supplementation in preschool children whose primary water source is 
deficient in fluoride and an “I” statement for the routine risk assessment of dental disease risk in 
preschool children by primary care physicians.64 In the second edition of the Guide, a specific 
chapter devoted to the prevention of dental carries in preschool children was not included; 
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however, a broader chapter on counseling for the prevention of dental and periodontal disease 
risk was included.65  While counseling for dental and periodontal disease is currently listed as an 
inactive topic on the USPSTF website, this chapter contained a non-counseling recommendation 
for the prescription of fluoride supplementation in some children. This recommendation was 
included in the comparison of the updated 2004 recommendation statement on the prevention of 
dental carries in preschool children with historical recommendations issued on the topic.
 
Categorization of updated recommendation statements based on their relationships to 
previously published recommendation statements 
  The breadth of preventive services (the topic) covered by a recommendation statement 
does not necessarily correspond precisely to the topic covered in a previously issued 
recommendation statement. Over time, several topics have been merged with others or have been 
split into separate topics.  To track changes in the scope of preventive services covered by 
individual recommendation statements, the scope of each recommendation statement was 
categorized on the basis of its relationship to previously issued recommendation statements.  As 
described in Table 2, an updated recommendation statement can cover the same topic as a 
previously issued recommendation statement, merge topics, split topics, mix topics, or evaluate a 
topic for the first time.  For this report, each recommendation statement was categorized on the 
basis of how the topic it covered mapped to the most recent previously issued recommendation 








Table A1. Classification of the topic covered by a recommendation statement based on its 
relation to previously issued recommendation statements  
Category Description and Illustrative Example 
Linear topic 
update66,67 
Occurs when the scope of preventive services covered by an updated 





Occurs when a preventive services subtopic is updated separately after 




Occurs when two preventive services topics that were previously evaluated 















2013: Screening for glaucoma2004: Screening for glaucoma
2002: Screening for Depression
2009: Screening and treatment for 
major depressive disorder in 
children and adolescents
2009: Screening for depression in 
adults
2016: Aspirin Use for the 
Primary Prevention of 
Cardiovascular Disease and 
Colorectal Cancer
2009: Aspirin for the Prevention 
of Cardiovascular Disease 
2007: Routine Aspirin or 
Nonsteroidal Anti-inflammatory 




Table A1. Continued.  
Mixing of 
topics38,72–74 
Occurs when subtopics from multiple previously issued recommendations 
statements and evaluated together in an updated recommendation statement 
 
New topic75 

















2017: Screening for Obstructive 
Sleep Apnea in Adults
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Illustrative examples of the assignment letter scores and intensity scores 
 
Table A2. Assignment of letter scores – Examples of possible scores 
Positive to more strongly positive 
Previous Recommendations Updated Recommendations 
 
1996: Screening for neural tube defects including 
folate prophylaxis31 
Periconceptual folic acid 4.0 mg daily for women 
with previous affected pregnancy 
A 
Daily multivitamin or multivitamin-multimineral 
supplement containing folic acid at a dose of 0.4-
0.8 mg for women planning pregnancy 
A 
Daily multivitamin containing 0.4 mg of folic 
acid for all women capable of becoming pregnant 
B 
Counseling women planning or capable of 
pregnancy to increase their dietary folate 
consumption to 0.4 mg per day as an alternative 
to taking multivitamins with folic acid 
C 
 
2009: Folic acid for the prevention of neural tube 
defects76 
A daily supplement containing 0.4 to 0.8 mg of 
folic acid for all women planning or capable of 
pregnancy  
A 
Explanation:  The “A” recommendation for folic acid supplementation in women planning 
pregnancy did not change. The “B” recommendation for folic acid supplementation in women 
capable of becoming pregnant changed to an “A” recommendation. 
Directionality: Positive 
Positive to equally as positive 
Previous Recommendations Updated Recommendations 
 
2008: Primary care interventions to promote 
breastfeeding77 
Interventions during pregnancy and after birth to 
promote and support breastfeeding 
B 
 
2016: Primary care interventions to promote 
breastfeeding78 
Interventions during pregnancy and after birth to 
promote and support breastfeeding 
B 
Explanation:  The “B” recommendation for providing interventions during pregnancy and after 
birth to support breastfeeding did not change. 
Directionality:  Neutral 
Positive to less strongly positive 
Previous Recommendations Updated Recommendations 
 
1996: Screening for tuberculous infection – including 
BCG vaccination31 
Screening for tuberculous infection by tuberculin 
skin testing for all persons at increased risk of 
developing tuberculosis 
A 




2016: Screening for latent tuberculosis infection in 
adults79 
Screening for latent tuberculosis infection in 
populations at increased risk 
B 
Explanation: The “A” recommendation in favor of screening for tuberculosis infection in 
persons at increased risk changed to a “B” recommendation. The recommendation regarding 




Table A2. Continued. 
Positive to neutral 
Previous Recommendations Updated Recommendations 
 
2006: Iron deficiency anemia screening and 
supplementation80 
Routine screening for iron deficiency anemia in 
asymptomatic pregnant women. 
B 




2015: Screening for iron deficiency anemia and iron 
supplementation in pregnant women to improve 
maternal health and birth outcomes81 
Screening for iron deficiency anemia in 
pregnant women to prevent adverse maternal 
health and birth outcomes 
I 
Routine iron supplementation for pregnant 
women to prevent adverse maternal health and 
birth outcomes 
I 
Explanation: The “B” recommendation for routine screening for iron deficiency anemia in 
asymptomatic pregnant women was changed to an “I” statement.  There was no change in the 
“I” statement regarding routine iron supplementation in pregnant women.  
Directionality: Negative 
Positive to negative 
Previous Recommendations Updated Recommendations 
 
1996: Postmenopausal hormone prophylaxis31  
Clinician counseling of all women around the 
time of menopause about the possible benefits 
and risks of postmenopausal hormone therapy 
and the available treatment options 
B 
 
2002: Postmenopausal hormone replacement therapy 
for the primary prevention of chronic conditions82  
Routine use of estrogen and progestin for the 
prevention of chronic conditions in 
postmenopausal women. 
D 
Use of unopposed estrogen for the prevention of 
chronic conditions in postmenopausal women 
who have had a hysterectomy 
I 
Explanation: In 1996, a “B” recommendation was issued for counseling women around 
menopause about the possible benefits and risks of postmenopausal hormone therapy and 
available treatment options noting that “insufficient evidence [is available] to recommend for 
or against hormone therapy for all postmenopausal women.”  In 2002, this recommendation 
changed to “D” recommendation against combined estrogen and progestin in postmenopausal 
















Table A2. Continued. 
Neutral to positive 




2003: Counseling to prevent tobacco use and tobacco-
caused disease83 
Screening for tobacco use or interventions to 
prevent and treat tobacco use and dependence 
among children or adolescents 
I 
Screening for all adults for tobacco use and 
Provision of tobacco cessation interventions for 
those who use tobacco products 
A 
Screening for all pregnant women for tobacco use 
and provision of augmented pregnancy-tailored 
counseling to those who smoke 
A 
 
2013: Primary care interventions to prevent tobacco 
use in children and adolescents84 
Primary care clinicians interventions, including 
education or brief counseling, to prevent 
initiation of tobacco use among school-aged 
children and adolescents 
B 
Explanation: While the 2013 recommendation statement focuses on interventions to prevent 
tobacco use initiation in children and adolescents, it also discusses evidence on the 
effectiveness of cessation interventions. It issued a “B” recommendation for primary care 
interventions to prevent the initiation of tobacco use in school-aged children and adolescents. 
In contrast, the 2003 statement found “little evidence addressing the effectiveness of … 
counseling children or adolescents to prevent the initiation of tobacco use.” It issued a 
corresponding “I” statement covering these interventions as well as screening and treatment 
interventions.  
Directionality: Positive 
Neutral to neutral 
Previous Recommendations Updated Recommendations 
 
2009: Screening for impaired visual acuity in older 
adults85 
Screening for visual acuity for the improvement 
of outcomes in older adults 
I 
 
2016: Screening for impaired visual acuity in older 
adults86 
Screening for impaired visual acuity in older 
adults 
I 
Explanation: The “I” statement issued for screening for visual acuity in older adults did not 
change. 
Directionality: Neutral 
Neutral to negative 
Previous Recommendations Updated Recommendations 
 
1996: Screening for asymptomatic carotid artery 
stenosis (CAS)31 
Insufficient evidence for or against screening 
asymptomatic persons for CAS, using physical 
examination or carotid ultrasound 
C 
 
2007: Screening for asymptomatic carotid artery 
stenosis87  
Screening for asymptomatic CAS in the general 
adult population 
D 
Explanation: In 1996, insufficient evidence was found to make a recommendation for or 
against screening for asymptomatic CAS. In 2007, a “D” recommendation against screening 





Table A2. Continued. 
Negative to positive 
Previous Recommendations Updated Recommendations 
 
2004: Screening for hepatitis B virus infection88 
Screening the general asymptomatic population 
for chronic hepatitis B virus infection 
D 
Screening for hepatitis B virus infection in 
pregnant women at their first prenatal visit A 
 
2014: Screening for hepatitis B virus infection in 
nonpregnant adolescents and adults39 
Screening for hepatitis B virus infection in 
persons at high risk for infection 
B 
Explanation:  In non-pregnant persons, the Task Force dropped the “D” recommendation for 
screening the general asymptomatic population for chronic hepatitis B virus infection in 
favoring of issuing a “B” recommendation for screening in persons at high risk of infection. 
Directionality: Positive 
Negative to neutral 
Previous Recommendations Updated Recommendations 
 
1996: Screening for thyroid disease31 
Insufficient evidence to recommend for or against 
screening for thyroid disease with thyroid 
function tests in high-risk patients 
C 
Routine screening for thyroid disease with 




2004: Screening for thyroid disease89 
Routine screening for thyroid disease in adults I 
Explanation: The “D” recommendation against the routine screening for thyroid disease in 
adults was changed to an “I” statement.  
Directionality: Positive 
Negative to less strongly negative 
Explanation: No topic updates received this letter score.  
Directionality: Positive 
Negative to equally as negative 
Previous Recommendations Updated Recommendations 
 
2008: Screening for chronic obstructive pulmonary 
disease (COPD) using spirometry90 
Screening adults for COPD using spirometry D 
 
2016: Screening for chronic obstructive pulmonary 
disease91 
Screening for chronic obstructive pulmonary 
disease COPD in asymptomatic adults 
D 










Table A2. Continued. 
Negative to more strongly negative 
Previous Recommendations Updated Recommendations 
 
2003: Routine vitamin supplementation to prevent 
cancer and cardiovascular disease92 
Use of beta-carotene supplements, either alone or 
in combination, for the prevention of cancer or 
cardiovascular disease 
D 
Use of supplements of vitamins A, C, or E; 
multivitamins with folic acid; or antioxidant 




2014:  Vitamin, mineral, and multivitamin 
supplements for the primary prevention of 
cardiovascular disease and cancer93 
Use of β-carotene or vitamin E supplements for 
the prevention of cardiovascular disease or 
cancer 
D 
Use of single- or paired-nutrient supplements 
(except β-carotene and vitamin E) for the 
prevention of cardiovascular disease or cancer. 
I 
Use of multivitamins for the prevention of 
cardiovascular disease or cancer 
I 
Explanation:  In 2003, the use of beta-carotene supplements for the prevention of cancer or 
cardiovascular disease (CVD) received a “D” recommendation. In 2014, this “D” 
recommendation was maintained. Additionally, the recommendation for the use of vitamin D 
in the prevention of cancer and CVD changed from an “I” statement to a “D” recommendation, 




Table B3. Assignment of intensity scores – Examples of possible scores 
Decreased intensity 
Previous Recommendations Updated Recommendations 
 
2002: Screening for colorectal cancer94  
Screening all men and women 50 years of age or 
older for colorectal cancer 
A 
 
2008: Screening for colorectal cancer95 
Screening for colorectal cancer using fecal 
occult blood testing, sigmoidoscopy, or 
colonoscopy in adults, beginning at age 50 years 
and continuing until age 75 years 
A 
Routine screening for colorectal cancer in adults 
76 to 85 years of age C 
Screening for colorectal cancer in adults older 
than age 85 years 
D 
Computed tomographic colonography and fecal 
DNA testing as screening modalities for 
colorectal cancer 
I 
Explanation: In 2002, the Task Force did not provide a specific recommendation regarding the 
age to discontinue screening for colorectal screening, but did state that “discontinuing 
screening is … reasonable in patients whose age or comorbid conditions limit life expectancy.”  
In 2008, the Task Force specifically recommended against screening in adults older than age 
85 years and issued a “C” recommendation for adults age 76 to 85 years. This change 
represents a decrease in the age range covered by the recommendation in favor of screening.  




Table A3. Continued. 
Same intensity 
Previous Recommendations Updated Recommendations 
 
2009: Folic acid for the prevention of neural tube 
defects76 
Daily supplement containing 0.4 to 0.8 mg (400 
to 800 µg) of folic acid for all women who are 
planning or capable of pregnancy 
A 
 
2017: Folic acid supplementation for the prevention 
of neural tube defects96 
Daily supplement containing 0.4 to 0.8 mg (400 
to 800 µg) of folic acid for all women who are 
planning or capable of pregnancy 
A 
Explanation:  The recommended population (all women who are capable of 
pregnancy) for folic acid supplementation and the recommended dosing did not change. Thus, 
the intensity of the recommended intervention remained the same. 
Increased intensity 
Previous Recommendations Updated Recommendations 
 
2009: Screening for depression in adults11 
Screening adults for depression when staff-
assisted depression care supports are in place to 
assure accurate diagnosis, effective treatment, 
and follow-up. 
B 
Screening adults for depression when staff-
assisted depression care supports are not in place. 
There may be considerations that support 
screening for depression in an individual patient. 
C 
 2016: Screening for depression in adults9 
Screening for depression in the general adult 
population, including pregnant and postpartum 
women. Screening should be implemented with 
adequate systems in place to ensure accurate 
diagnosis, effective treatment, and appropriate 
follow-up. 
B 
Explanation: The 2009 “B” recommendation in favor of screening adults for depression 
applied to “nonpregnant adults, including older adults.”  The 2016 “B” recommendation in 
favor of screening applied a broader population, additionally including pregnant and 
postpartum women. This increase in the breadth of the population covered by the 





















Examples of challenging topic updates to assign letter and intensity scores 
 
Table A4. Assignment of Letter and Intensity Scores – Examples of Challenging Cases 
Example 1 
Previous Recommendations Updated Recommendations 
 
2007: Routine aspirin or nonsteroidal anti-
inflammatory drugs (NSAIDs) for the primary 
prevention of colorectal cancer (CRC)70 
Routine use of aspirin and NSAIDs to prevent 
colorectal cancer in individuals at average risk for 
colorectal cancer  
D 
2009: Aspirin for the prevention of cardiovascular 
disease (CVD)69 
Use of aspirin for men age 45 to 79 years when 
the potential benefit due to a reduction in 
myocardial infarctions outweighs the potential 
harm due to an increase in gastrointestinal 
hemorrhage 
A 
Use of aspirin for women age 55 to 79 years 
when the potential benefit of a reduction in 
ischemic strokes outweighs the potential harm of 
an increase in gastrointestinal hemorrhage 
A 
Use of aspirin for cardiovascular disease 
prevention in men and women 80 years or older 
I 
Use of aspirin for stroke prevention in women 
younger than 55 years and for myocardial 




2016: Aspirin use for the primary prevention of 
cardiovascular disease and colorectal cancer71 
Low-dose aspirin use for the primary prevention 
of CVD and CRC in adults aged 50 to 59 years 
who have a 10% or greater 10-year CVD risk 
(and additional population specifiers) 
B 
Low-dose aspirin use for the primary prevention 
of CVD and CRC in adults aged 60 to 69 years 
who have a 10% or greater 10-year CVD risk 
(and additional population specifiers) 
C 
Aspirin use for the primary prevention of CVD 
and CRC in adults younger than 50 years 
I 
Aspirin use for the primary prevention of CVD 
and CRC in adults aged 70 years or older. 
I 
Letter Score 
• Option 1: Positive to less strongly positive. The 2007 and 2009 recommendation 
statements included separate “A” recommendations for aspirin use in populations of 
both men and women. The 2016 recommendation statement gave “B” and “C” 
recommendations for different age groups based on CVD risk.  Based on this change, a 
letter score of “positive to less strongly positive” could be assigned. 
• Option 2: Negative to neutral. The 2009 recommendation statement gave a “D” 
recommendation for aspirin use in women younger than 55 and men younger than 45; 
whereas, the 2016 recommendation statement issued an “I” statement for aspirin use in 
adults younger than 50.  Based on this change, a letter score of “negative to neutral” 
could be assigned. 
• Additionally, the 2016 recommendation statement evaluated the use aspirin for the 
prevention of CRC and CVD concurrently. Thus, the 2007 “D” recommendation 
against the use of aspirin to prevent CRC across all populations was incorporated into 
several updated recommendations. Given the absence of clear linkages between the 
2007 “D” recommendation and the updated recommendations, this recommendation 
was not considered in the assignment of the letter score. 
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• Rule 1:  For cases in which the grade of both negative and positive recommendations 
change, prioritize the change in the positive recommendations in the assignment of a 
letter score. 
• Application of Rule 1:  Application of Rule 1 leads to the selection of “positive to 
less strongly positive” as the letter score 
Intensity Score 
• The recommended age ranges for aspirin use became smaller in breadth.  The updated 
recommendations also include additional population specifiers (10% or greater 10-year 
CVD risk, life expectancy of at least 10 years, no increased risk of bleeding, and 
willingness to take low-dose aspirin for at least 10 years). For these reasons, the 
population size for which aspirin use is recommended decreased. As such, an intensity 
score of “decreased intensity” is appropriate. 
Example 2 
Previous Recommendations Updated Recommendations 
 
2002: Screening for breast cancer45 
Screening mammography, with or without 
clinical breast examination (CBE), every 1-2 
years for women aged 40 and older 
B 
Routine CBE alone to screen for breast cancer I 




2009: Screening for breast cancer36 
Biennial screening mammography for women 
between the ages of 50-74 years 
B 
Routine screening mammography in women 
aged 40 to 49 years 
C 
Screening mammography in women 75 years 
and older 
I 
Clinicians teaching women how to 
perform breast self-examination 
D 
Clinical breast examination beyond screening 
mammography in women 40 years or older 
I 
Digital mammography or magnetic resonance 
imaging instead of film mammography as 
screening modalities for breast cancer 
I 
Letter Score 
• Option 1: Positive to less strongly positive. In women ages 40 to 49, the 
recommendation grade for screening mammography changed from “B” to “C”.  
Additionally, for women ages 75 or older, the recommendation grade changed from 
“B” to “I”. The grade remained a “B” for women ages 50 to 74.  Based on these 
changes, a letter score of “positive to less strongly positive” could be assigned. 
• Option 2: Neutral to negative. The recommendation for teaching women how to 
perform the breast self-examination changed form “I” to “D”. Based on this change, a 
letter score of “neutral to negative” could be assigned. 
• Rule 2: For cases in which the grade of both neutral and positive recommendations 
change, prioritize the change in the positive recommendations in the assignment of a 
letter score. 
• Application of Rule 2:  Application of Rule 2 leads to the selection of “positive to 




• The recommended age range for mammography screening decreased. Furthermore, the 
recommended screening interval decreased from every 1-2 years to every 2 years. 
These changes correspond to an intensity score of “decreased intensity”. 
Example 3 
Previous Recommendations Updated Recommendations 
 
2008: Screening for colorectal cancer95 
Screening for colorectal cancer using fecal occult 
blood testing, sigmoidoscopy, or colonoscopy in 
adults, beginning at age 50 years and continuing 
until age 75 years 
A 
Routine screening for colorectal cancer in adults 
76 to 85 years of age 
C 
Screening for colorectal cancer in adults older 
than age 85 years 
D 
Computed tomographic (CT) colonography and 
fecal DNA testing as screening modalities for 
colorectal cancer.  
I 
 
2016: Screening for colorectal cancer41 
Screening for colorectal cancer starting at age 50 
years and continuing until age 75 years 
A 




• The “A” recommendation for screening for colorectal cancer (CRC) in adults ages 50 
to 75 did not change. Similarly, the “C” recommendation for screening for CRC in 
adults ages 76 to 85 (although the definition of the “C” grade changed) did not change.   
• Notably, the 2008 “D” recommendation for screening for CRC was dropped; no 
recommendation was given for this population in the updated 2016 recommendation 
statement. Within the text of the recommendation statement, however, the Task Force 
comments that “the USPSTF does not recommend routine screening for colorectal 
cancer in adults 86 years and older.”  Nevertheless, since this recommendation was not 
updated in the 2016 recommendation statement, it was not considered in the 
assignment of the letter score.  
• Similarly, since the 2008 recommendation regarding CT colonography and fecal DNA 
testing as screening modalities was not updated in 2016, it was not considered in the 
assignment of the letter score.  
• Given that both the “A” recommendation for screening adults ages 50 to 75 and the 
“C” recommendation for screening adults ages 76 to 85 remained unchanged, a letter 
score of “positive to equally as positive” is appropriate.  
Intensity Score 
• In its 2016 recommendation on colon cancer screening, the USPSTF decided against 
emphasizing specific screening approaches and “instead [chose] to highlight there is 
convincing evidence that colorectal cancer screening substantially reduces deaths from 
the disease in adults aged 50 to 75 years.”  Because the USPSTF provided no specific 
guidance on recommended screening modalities or screening intervals in this 
recommendation statement, the change in the intervention intensity cannot be inferred. 
For this reason, an intensity score of “same intensity” is appropriate. 
Example 4 




1996: Screening for colorectal cancer31 
Screening all persons aged 50 or over for CRC 
using fecal occult blood testing (FOBT) 
B 
Screening all persons aged 50 or over for CRC 
using sigmoidoscopy 
B 
Insufficient evidence for or against routine 
screening with digital rectal examination 
C 
Insufficient evidence for or against routine 
screening with barium enema 
C 
Insufficient evidence for or against routine 
screening with colonoscopy 
C 
 
2002: Screening for colorectal cancer94  
Screening all men and women 50 years of age or 
older for colorectal cancer.  
A 
Letter Score 
• The strength of the recommendation for screening all person age 50 and older for 
colorectal cancer increased from an “B” recommendation to a “A” recommendation. 
This change corresponds to a letter score “positive to more strongly positive” 
Intensity Score 
• The 2002 recommendation statement notes that fair to good evidence demonstrates 
several screening methods are effective in reducing mortality from colorectal cancer. It 
stops short, however, of making specific recommendations regarding the optimal 
screening modality or screening interval. As such, there is no clear change in the 
intensity of the recommended screening interventions. An intensity score of “same 
intensity” is most appropriate. 
Example 5 
Previous Recommendations Updated Recommendations 
 
2008: Screening for type 2 diabetes mellitus in adults97 
Screening for type 2 diabetes in asymptomatic 
adults with sustained blood pressure (either 
treated or untreated) greater than 135/80 mm Hg 
B 
Screening for type 2 diabetes in asymptomatic 
adults with blood pressure of 135/80 mm Hg or 
lower. 
I 
 2015: Screening for abnormal blood glucose and type 
2 diabetes mellitus98 
Screening for abnormal blood glucose as part of 
cardiovascular risk assessment in adults aged 40 
to 70 years who are overweight or obese 
B 
Letter Score 
• The “B” recommendation for screening a subpopulation of patients for abnormal blood 
glucose/type 2 diabetes mellitus did not change.  
• Notably, in 2008, the recommendation in favor of screening adults with sustained 
blood pressure greater than 135/80 mm Hg was based on evidence that lowering blood 
pressure below conventional target values in patients with hypertension and diabetes 
reduces the incidence of cardiovascular events and cardiovascular mortality.   
• In contrast, the 2015 recommendation in favor of screening applied to the population of 
patients most likely to have glucose abnormalities who could benefit from intensive 
lifestyle interventions to reduce cardiovascular disease (CVD) risk, namely adults aged 
40 to 70 years who are overweight or obese.  
• While the specific subpopulations covered by the updated and previous 
recommendations in favor of screening differed, in both instances a “B” 
recommendation was issued for a subset of primary care patients at increased CVD 




• In 2008, screening was recommended for all adults with a blood pressure of 135/80 
mm Hg or greater. In 2015, however, the recommendation in favor of screening was 
based on age and weight (all adults aged 40 to 70 years who are overweight or obesity).  
Notably, the updated “B” recommendation applies to screening to detect glucose 
abnormalities, while the prior recommendation applied to screening to detect diabetes 
mellitus. This difference represents an increase in the sensitivity of the screening 
intervention.  The updated recommendation statement notes that “since the previous 
recommendation … studies have shown consistent benefit of lifestyle medication to 
prevent or delay progression to diabetes.”  The change in the sensitivity of the 
recommended screening intervention corresponds to an intensity score of “increased 
intensity”. 
Example 6 
Previous Recommendations Updated Recommendations 
 
1996: Screening for hypertension31 
Periodic screening for hypertension for persons 
greater than or equal to 21 years of age 
A 
Measurement of blood pressure during office 
visits for children and adolescents (based on the 
proven benefits from the early detection of 
treatable causes of secondary hypertension) 
B 
 
2003: Screening for high blood pressure99 
Screen adults aged 18 and older for high blood 
pressure 
A 
Screening for high blood pressure in children 




• The “A” recommendation for screening adults remained unchanged. The “B” 
recommendation for screening children and adolescents changed to an “I” statement. 
Thus, the overall letter score is “positive to less strongly positive”. 
Intensity Score 
• Option 1: Increased intensity. The recommended age range for screening adults 
changed from 21 and older to 18 and older. This change represents an increase in the 
size of the population covered by the recommendation. Based on this change, an 
intensity score of “increased intensity” could be assigned. 
• Option 2: Decreased intensity. The “B” recommendation for screening children and 
adolescents changed to an “I” statement. This change represents a decrease in the size 
of the population the Task Force recommended screening for hypertension. Based on 
this change, an intensity score of “decreased intensity” could be assigned. 
• Children and adolescents represent a larger population than adults ages 18 to 21. For 
this reason, the overall change in the population covered by a recommendation for 
screening for hypertension decreased in size. As such, an intensity score of “decreased 
intensity” is most appropriate.   
Example 7 




1996: Screening for iron deficiency anemia including 
iron prophylaxis31  
Hemoglobin analysis or hematocrit for pregnant 
women at their first prenatal visit 
B 
Insufficient evidence for or against routine use of 
iron supplements for healthy pregnant women 
who are not anemic 
C  
Insufficient evidence for or against repeated 
prenatal testing for anemia in asymptomatic 
pregnant women lacking evidence of medical or 
obstetrical complication or high-risk infants not 
anemic at initial testing 
C 
Screening for anemia with hemoglobin or 
hematocrit in high-risk infants, preferably at 6-12 
months of age 
B 
Insufficient evidence to recommend for or against 
routine testing for anemia in other asymptomatic 
persons 
C 
Insufficient evidence for or against routine use of 
iron supplements for healthy infants who are not 
anemic 
C 
Insufficient evidence for or against routine testing 
for anemia in high-risk children 
C 
Encouraging mothers to breastfeed their infants 
and advising parents to include iron-enriched 
foods in the diet of infants and young children  




2006: Screening for iron deficiency anemia including 
iron supplementation for children and pregnant 
women80 
Screening for iron deficiency anemia in 
asymptomatic pregnant women 
B 
Routine iron supplementation for non-anemic 
pregnant women 
I 
Routine screening for iron deficiency anemia in 
asymptomatic children aged 6 to 12 months I 
Routine iron supplementation for asymptomatic 
children aged 6 to 12 months who are at 
increased risk for iron deficiency anemia 
B 
Routine iron supplementation for asymptomatic 
children aged 6 to 12 months who are at average 
risk for iron deficiency anemia. 
I 
Letter Score 
• Both recommendation statements cover four subtopics:  screening for anemia in 
pregnant women, iron supplementation in pregnant women, screening for anemia in 
children, and iron supplementation in children. 
• Unlike the 1996 recommendation statement, the 2006 statement does not include 
specific recommendations regarding repeat testing for anemia in pregnant women and 
high-risk infants, routine testing for anemia in high-risk children (older than 12 
months), or breastfeeding and the use of iron-enriched foods in the diet of infants and 
young children. 
• Screening in pregnant women:  Both statements issued a “B” recommendation for 
screening pregnant women for anemia. The 2006 statement noted that “the USPSTF 
found … no studies that specifically addressed the accuracy of screening tests in 
asymptomatic women,” but stated that hemoglobin is a sensitive test for iron deficiency 
anemia.   
• Iron supplementation in pregnant women: Both statements found insufficient 
evidence to issue a recommendation regarding routine iron supplementation in 
pregnant women. 
• Screening in children: In 1996, a “B” recommendation was issued for screening 
infants (ages 6 to 12 months) at increased risk of iron deficiency anemia. For infants at 
average risk of iron deficiency anemia, insufficient evidence existed to make a 
recommendation for or against screening (this population is presumably covered by the 
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recommendation for screening in other asymptomatic persons). Similarly, in 2006, 
insufficient evidence was found to issue a recommendation regarding routine screening 
in asymptomatic infants. Unlike in 1996, a specific recommendation for screening 
infants at high risk of iron deficiency anemia was not issued in 2006.  
• Iron supplementation in children: Both statements found insufficient evidence to 
issue a recommendation regarding routine iron supplementation in asymptomatic 
infants. In 2006, however, a “B” recommendation was issued routine iron 
supplementation in asymptomatic children at increased risk for iron deficiency anemia. 
• No changes in grades were made for comparable recommendations in 2006 compared 
to 1996. As such, the appropriate letter score is “positive to equally as positive”.   
Intensity Score 
• From 1996 to 2006, the intensity of the recommended screening intervention for 
pregnant women did not clearly change. 
• In 1996, a “B” recommendation was issued for screening high-risk infants for iron 
deficiency anemia. In 2006, a “B” recommendation was issued for the routine iron 
supplementation in infants at increased risk of iron deficiency anemia.  The 2006 
recommendation represents an increase in the intensity of the recommended 
intervention because it does not require screening of high-risk infants for anemia prior 
to the use of iron supplementation.  Thus, an intensity score of  “increased intensity” 
is appropriate. 
Example 8 
Previous Recommendations Updated Recommendations 
 
2005: Screening for abdominal aortic aneurysm100 
One-time screening for abdominal aortic 
aneurysm (AAA) by ultrasonography in men 
aged 65-75 who have ever smoked 
B 
Screening for AAA in men aged 65-75 who have 
never smoked. 
C 
Routine screening for AAA in women D 
 
2014: Screening for abdominal aortic aneurysm101 
One-time screening for AAA with 
ultrasonography in men ages 65 to 75 years who 
have ever smoked 
B 
Screening for AAA in men ages 65 to 75 years 
who have never smoked 
C 
Screening for AAA in women ages 65 to 75 
years who have ever smoked I 




• The “B” recommendation for screening men ages 65 to 75 who have ever smoked did 
not change. 
• The “D” recommendation against screening women who have never smoked did not 
change (in 2005, this population is included in the “D” recommendation against 
screening for AAA in all women). 
• In 2014, an “I” statement was issued for screening women ages 65 to 75 who have ever 
smoked.  In 2005, the “D” recommendation against routine screening in women 
applied to this population.   
• Overall, a letter score of “positive to more strongly positive” is appropriate because 
the recommendation against screening became more positive in women ages 65 to 75 
who have ever smoked (shifting from a “D” recommendation to an “I” statement) 




• Option 1: Increased intensity. The decrease in the size of the population covered by 
the “D” recommendation against screening in women could result in a greater number 
of women who are screened (although, the “I” statement for women ages 65 to 75 who 
have ever smoked does not provide guidance for or against screening).  As such, an 
intensity score of “increased intensity” could be assigned. 
• Option 2: Same intensity. The recommendations for screening in men remained 
unchanged. In both recommendation statements, no sub-population of women received 
a positive recommendation for screening.  Thus, there was no change in the size of the 
population receiving a positive recommendation for screening.    
• Rule 3: Only consider changes in the intensity of interventions and populations 
receiving positive recommendations when assigning an intensity score. 
• Application of Rule 3: Application of Rule 3 leads to the selection of “same 
intensity” as the intensity score. 
Example 9 
Previous Recommendations Updated Recommendations 
 
1996: Screening for abdominal aortic aneurysm31 
Insufficient evidence for or against routine 
screening for AAA with abdominal palpation 
C 
Insufficient evidence for or against routine 
screening for AAA with ultrasound 
C 
 
2005: Screening for abdominal aortic aneurysm100 
One-time screening for AAA by 
ultrasonography in men aged 65-75 who have 
ever smoked 
B 
Screening for AAA in men aged 65-75 who 
have never smoked. C 
Routine screening for AAA in women D 
Letter Score 
• Option 1: Neutral to neutral.  In 1996, insufficient evidence was found to make a 
recommendation for or against for screening for AAA with ultrasound. In 2005, a “B” 
recommendation was issued in favor of screening for AAA in a sub-population of men 
and a “D” recommendation was issued against screening in women. One could argue 
that these because recommendations are in opposite directions, the overall 
directionality of the 2005 recommendations for AAA screening is neutral. Under this 
interpretation, a letter score of “neutral to neutral” would be appropriate.   
• Option 2: Neutral to positive. If the positive recommendation for screening for AAA 
in a subset of men is prioritized over the recommendation against screening in women, 
a letter score of “neutral to positive” would result. 
• Rule 4: For cases in which a previously neutral recommendation(s) changes to a 
positive recommendation in one subpopulation and a negative recommendation in 
another subpopulation, prioritize the positive recommendation in the assignment of a 
letter score. 
• Application of Rule 4: Application of Rule 4 leads to the selection of “neutral to 
positive” as the letter score.  
Intensity Score 
• Not applicable because the 1996 recommendation statement did not include a positive 
recommendation for screening for AAA in any population. 
Example 10 




2005: Screening for gonorrhea72 
Screening all sexually active women, including 
those who are pregnant, for gonorrhea infection if 
they are at increased risk for infection 
B 
Routine screening for gonorrhea infection in men 
at increased risk for infection 
I 
Routine screening for gonorrhea infection in men 
and women who are at low risk for infection 
D 
Routine screening for gonorrhea infection in 
pregnant women who are not at increased risk for 
infection 
I 
Topical medication for all newborns against 
gonococcal ophthalmia neonatorum 
A 
2007: Screening for chlamydia73 
Screening for chlamydial infection for all 
sexually active nonpregnant young women age 24 
years or younger and older nonpregnant women 
who are at increased risk 
A 
Screening for chlamydial infection for all 
pregnant women age 24 years or younger and for 
older pregnant women who are at increased risk 
B 
Screening for chlamydial infection for women 
age 25 years or older, regardless of whether they 
are pregnant, if they are not at increased risk 
C 
Screening for chlamydial infection for men I 
 
2014: Screening for chlamydia and gonorrhea38  
Screening for chlamydia in sexually active 
women age 24 years and younger and in older 
women who are at increased risk for infection 
B 
Screening for gonorrhea in sexually active 
women age 24 years and younger and in older 
women who are at increased risk for infection 
B 
Screening for chlamydia and gonorrhea in men I 
Letter Score 
• For gonorrhea, the USPSTF issued a “B” recommendation for screening all sexually 
active women at increased risk of infection in both 2005 and 2014.  
• In 2005, the USPSTF also issued a “D” recommendation against routine screening for 
gonorrhea infection in men and women who are at low risk for infection.  No 
recommendation for screening persons at low-risk of gonorrheal infection was 
provided in 2014. Similarly, the “I” statement issued in 2005 for screening pregnant 
women who are not at increased risk for infection was not updated in 2014. 
• Insufficient evidence was available in 2014 to issue a recommendation for or against 
routine screening for either chlamydia or gonorrhea in men. Similar “I” statements 
were issued in 2005 for gonorrhea screening in men at increased of infection and in 
2007 for chlamydial screening in all men 
• For chlamydial screening in women, the USPSTF issued a “C” recommendation in 
2007 for routinely screening in women 25 and older if not at increased risk of 
infection. No recommendation was provided for this group in 2014.  
• The USPSTF also issued a “B” recommendation in 2014 for chlamydial screening in 
sexually active women, including pregnant women, ages 24 years and younger and 
older women at increased risk of infection. In 2007, two recommendations were issued 
for this population of women: a “B” recommendation for the pregnant women in this 
group and an “A” recommendation for nonpregnant women in this group.  Since the 
recommendation for the nonpregnant women in this group changed from an “A” 
recommendation to a “B” recommendation, an overall letter score of “positive to less 
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strongly positive” may be appropriate given this is the only clear recommendation 
change made.  
Intensity Score 
• No clear changes were made in the recommended screening intervals, screening 
modalities, or populations covered by positive recommendations. Thus, an intensity 
score of  “same intensity” is appropriate. 
Example 11 
Previous Recommendations Updated Recommendations 
 
1996: Screening for chlamydial infection31  
Routine screening for chlamydia for all sexually 
active female adolescents and for other women at 
high risk for chlamydial infection 
B 
Routine screening of pregnant women at high risk 
of infection (including age under 25) 
B 
Insufficient evidence to recommend for or against 
screening all women during pregnancy 
C 
Routine screening for chlamydia is not 
recommended in the general population of low-
risk adults 
D 
Insufficient evidence to recommend for or against 
routine screening in high-risk men 
C 
 
2001: Screening for chlamydial infection102 
Routinely screening all sexually active women 
aged 25 and younger, and other asymptomatic 
women at increased risk for infection, for 
chlamydial infection 
A 
Routinely screening all asymptomatic pregnant 
women aged 25 and younger and others at 
increased risk for infection for chlamydial 
infection 
B 
Routine screening all asymptomatic low-risk 
pregnant women aged 26 and older for 
chlamydial infection. 
C 
Routinely screening asymptomatic low-risk 
women in the general population for chlamydial 
infection 
C 




• The 1996 “D” recommendation against screening in the general population of low-risk 
adults changed to a “C” recommendation for asymptomatic low-risk women and to an 
“I” statement for asymptomatic men.  
• Additionally, the 1996 “B” recommendation for screening young sexually active 
women and other high-risk women changed to an “A” recommendation.  
• The “B” recommendation for screening high-risk pregnant women remained 
unchanged. 
• The insufficient evidence grade for screening low-risk pregnant women changed to a 
“C” recommendation (a neutral change).  The insufficient evidence grade for screening 
high-risk men was broadened to include all asymptomatic men.  
• Recall Rule 1:  For cases in which the grade of both negative and positive 
recommendations change, prioritize the change in the positive recommendations in the 
assignment of a letter score. 
• Application of Rule 1: Given the change in the “B” recommendation for screening 
young sexually active women and other high-risk women to an “A” recommendation, a 
letter score of “positive to more strongly positive” is appropriate. 
Intensity Score 
• In 2001, the Task Force did not provide specific guidance on the choice of screening 
the test or the optimal screening interval or timing of screening in pregnancy. 
Furthermore, no change was made in the populations issued positive recommendations 




Previous Recommendations Updated Recommendations 
 
2003: Behavioral counseling in primary care to 
promote a healthy diet61 
Intensive behavioral dietary counseling for adult 
patients with hyperlipidemia and other known 
risk factors for cardiovascular and diet-related 
chronic disease by primary care clinicians or by 
referral to other specialists, such as nutritionists 
or dietitians. 
B 
Routine behavioral counseling to promote a 
healthy diet in unselected patients in primary care 
settings 
I 
2002: Behavioral counseling in primary care to 
promote physical activity59 
Behavioral counseling in primary care settings to 
promote physical activity 
I 
 
2014: Behavioral counseling interventions to promote 
a healthful diet and physical activity for cardiovascular 
disease prevention in adults with cardiovascular risk 
factors103 
Offering or referring adults who are overweight 
or obese and have additional cardiovascular 
disease (CVD) risk factors to intensive behavioral 
counseling interventions to promote a healthful 
diet and physical activity for CVD prevention 
B 
Letter Score 
• The “B” recommendation for behavioral counseling to promote a healthy diet in a 
subset of adults with cardiovascular disease risk factors did not change.   
• For behavioral counseling to promote physical activity, a recommendation specific to 
adults with cardiovascular risk factors had not previously been issued.  
• As such, the most appropriate letter score is “positive to equally as positive”. 
Intensity Score 
• The breadth of interventions recommended in the 2014 recommendations is greater and 
includes interventions to improve healthy eating, increase physical activity, or a 
combination of approaches to develop a healthier lifestyle.  In contrast, only intensive 
dietary counseling was previously recommended in adults with cardiovascular risk 
factors. For this reason, an intensity score of “increased intensity” is appropriate. 
• In 2003, a “B” recommendation was issued in favor of dietary counseling for all adult 
patients with hyperlipidemia and other known CVD risk factors, including normal 
weight patients. Conversely, the 2014 recommendation only applies to overweight or 
obese adults with CVD risk factors. No recommendation was issued for normal weight 
adults with CVD risk factors. This change does not necessarily imply a decrease in the 
breadth of the population covered by the recommendation for dietary counseling, 
however, because no recommendation was issued in 2014 for normal weight 
individuals with CVD risk factors. 
Example 13 




1996: Screening for hepatitis B virus (HBV) infection31 
Screening for HBV infection for all pregnant 
women at their first prenatal visit  
A 
Routine screening for HBV infection in the 
general population 
D 
Insufficient evidence for or against routinely 




2004: Screening for hepatitis B virus infection88 
Screening for HBV infection in pregnant women 
at their first prenatal visit. 
A 
Routinely screening the general asymptomatic 
population for chronic HBV infection 
D 
Letter Score 
• Rule 5: If previously issued and updated recommendation statements issue both 
positive and negative recommendations for an intervention in different subpopulations, 
prioritize the positive recommendations in the assignment of a letter score. 
• Application of Rule 5: The “A” recommendations for screening all pregnant women 
and the “D” recommendations against screening in the general population did not 
change. Thus, application of Rule 5 leads to the selection of “positive to equally as 
positive” as the letter score. 
Intensity Score 
• For pregnant women, the recommendation for screening for HBV infection at the first 
prenatal visit did not change. Neither recommendation specifies an optimal screening 
modality. Thus, an intensity score of  “same intensity” is appropriate. 
Example 14 
Previous Recommendations Updated Recommendations 
 
2002: Chemoprevention of breast cancer104 
Clinicians should discuss chemoprevention with 
women at high risk for breast cancer and at low 
risk for adverse effects of chemoprevention  
B 
Routine use of tamoxifen or raloxifene for the 
primary prevention of breast cancer in women at 
low or average risk for breast cancer. 
D 
 
2013: Medications for risk reduction of primary breast 
cancer in women105 
For women at increased risk for breast cancer and 
at low risk for adverse medication effects, 
clinicians should offer to prescribe risk-reducing 
medications, such as tamoxifen or raloxifene 
B 
Routine use of medications, such as tamoxifen or 
raloxifene, for risk reduction of primary breast 




• Recall Rule 5: If previously issued and updated recommendation statements issue both 
positive and negative recommendations for an intervention in different subpopulations, 
prioritize the positive recommendations in the assignment of a letter score. 
• Application of Rule 5: The “B” recommendations for discussing harms and benefits 
of breast cancer chemoprevention in women at increased risk for breast cancer and at 
low risk for adverse medication effects did not change. Similarly, the “D” 
recommendations against the routine use of medications for the risk reduction of breast 
cancer in low or average risk women did not change. Thus, application of Rule 5 leads 
to the selection of “positive to equally as positive” as the letter score. 
Intensity Score 
• The recommendations did not change. Thus, the an intensity score of  “same 




Previous Recommendations Updated Recommendations 
 
2004: Screening for hepatitis C virus infection in 
adults106 
Routine screening for hepatitis C virus (HCV) 
infection in asymptomatic adults who are not at 
increased risk  
D 
Routine screening for HCV infection in adults at 
high risk for infection 
I 
 
2013: Screening for hepatitis C virus infection in 
adults40 
Screening for HCV infection in persons at high 
risk for infection and for adults born between 
1945 and 1965 
B 
Letter Score 
• In 2004, a “D” recommendation was issued against screening in persons not at 
increased risk of infection. In 2013, a positive “B” recommendation was issued for 
screening in persons at high risk for infection. While these subpopulations are 
different, the recommendations represent a change from an overall recommendation 
against screening in a subset of adults to a recommendation in favor of screening in a 
subset of adults.  As such, the most appropriate letter score is “negative to positive”.   
Intensity Score 
• Not applicable 
Example 16 
Previous Recommendations Updated Recommendations 
 
2003: Screening for cervical cancer107  
Screening for cervical cancer in women who have 
been sexually active and have a cervix 
A 
Routine use of HPV testing as a primary 
screening test for cervical cancer 
I 
Routine use of new technologies to screen for 
cervical cancer, such as liquid-based cytology, 
computerized rescreening, and algorithm based 
screening 
I 
Routine Pap smear screening in women who have 
had a total hysterectomy for benign disease 
D 
Routinely screening women older than age 65 for 
cervical cancer if they have had adequate recent 
screening with normal Pap smears and are not 
otherwise at high risk for cervical cancer 
D 
 
2012: Screening for cervical cancer108 
Screening for cervical cancer in women age 21 to 
65 years with cytology (Pap smear) every 3 years 
or, for women age 30 to 65 years who want to 
lengthen the screening interval, screening with a 
combination of cytology and HPV testing every 5 
years 
A 
Screening for cervical cancer with HPV testing, 
alone or in combination with cytology, in women 
younger than age 30 years 
D 
Screening for cervical cancer in women younger 
than age 21 years 
D 
Screening for cervical cancer in women older 
than age 65 years who have had adequate prior 
screening and are not otherwise at high risk for 
cervical cancer 
D 
Screening for cervical cancer in women who have 
had a hysterectomy with removal of the cervix 
and who do not have a history of a high-grade 
precancerous lesion (cervical intraepithelial 
neoplasia [CIN] grade 2 or 3) or cervical cancer 
D 
Letter Score 
• Both recommendation statements issued “D” recommendations against screening in 
women older than age 65 (with adequate prior screening) and in women with total 
hysterectomy (without a history of high-grade lesions).   
• Additionally, both recommendation statements issued “A” recommendations for 
screening in subsets of adult women.  
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• Recall Rule 5: If previously issued and updated recommendation statements issue both 
positive and negative recommendations for an intervention in different subpopulations, 
prioritize the positive recommendations in the assignment of a letter score. 
• Application of Rule 5: The “A” recommendations for screening in a subset of women 
and the “D” recommendations against screening in a subset of women did not change. 
Thus, application of Rule 5 leads to the selection of “positive to equally as positive” 
as the letter score. 
Intensity Score 
• The updated recommendations provide guidance on the appropriate age ranges and 
intervals for screening, including a new recommendation that women younger than age 
21 not be screened. In contrast, the 2003 recommendation statement comments that “no 
direct evidence [demonstrates] annual screening achieves better outcomes than 
screening every 3 years,” but stops short of providing a recommended interval for 
screening. The 2012 recommendation statement also issued a new recommendation 
against screening women younger than age 30 with HPV testing; whereas, an "I" 
statement had previously been issued for the routine use of HPV testing as a primary 
screening test.    
• Overall, in 2003, the recommendations in favor of screening covered a slightly broader 
population compared to the 2012 recommendations. Unlike in 2012, for instance, the 
Task Force recommended screening women younger than 21 if they had been sexually 
active for at least three years. Given this decrease in the breadth of the population 
covered by a recommendation in favor of screening, an intensity score of “decreased 
intensity” is appropriate. 
Example 17 
Previous Recommendations Updated Recommendations 
 
1996: Screening for cervical cancer31  
Regular Pap tests for all women who are or have 
been sexually active and who have a cervix 
performed at least every 3 years 
A 
Insufficient evidence to recommend for or against 
an upper age limit for Pap testing 
(recommendations to discontinue testing in 
women older than 65 who have had regular 
previous screening may be made on other 
grounds)  
C 
Insufficient evidence to recommend for or against 
routine cervicography or colposcopy screening 
for cervical cancer in asymptomatic women 
C 
Insufficient evidence to recommend for or against  
routine testing for HPV infection 
C 
 
2003: Screening for cervical cancer107  
Screening for cervical cancer in women who have 
been sexually active and have a cervix 
A 
Routine use of HPV testing as a primary 
screening test for cervical cancer 
I 
Routine use of new technologies to screen for 
cervical cancer, such as liquid-based cytology, 
computerized rescreening, and algorithm based 
screening 
I 
Routine Pap smear screening in women who have 
had a total hysterectomy for benign disease 
D 
Routinely screening women older than age 65 for 
cervical cancer if they have had adequate recent 
screening with normal Pap smears and are not 
otherwise at high risk for cervical cancer 
D 
Letter Score 
• The “A” recommendation for screening a subset of sexually active adult women did 
not change. 
• In 2003, a “D” recommendation was issued for women older than 65 if they have had 
adequate recent screening with normal Pap smears. Previously, insufficient evidence 




• Given the change from an “I” statement to a “D” recommendation against screening in 
a subset of older women and the unchanged “A” recommendation for screening in 
sexually active women with a cervix, a letter score of “positive to less strongly 
positive” is appropriate.  
Intensity Score 
• No specific guidance was given in either recommendation statement regarding the 
frequency of screening; although, the lack of evidence in favor of screening more 
frequently than every 3 years was mentioned in both statements. 
• In 2003, the upper age limit set for screening represents a decrease in the size of the 
population in which to perform screening.  As such, an intensity score of “decreased 
intensity” is most appropriate.  
Example 18 
Previous Recommendations Updated Recommendations 
 1996: Screening for asymptomatic coronary artery 
disease31  
Routine ECG screening as part of the periodic 
health visit or pre-participation sports physical is 
not recommended for asymptomatic children, 
adolescents, and young adults 
D 
Insufficient evidence to recommend for or against 
screening middle-aged and older men and women 
for asymptomatic coronary artery disease (CAD) 
with resting electrocardiography (ECG), 
ambulatory ECG, or exercise ECG 
C 
 
2004: Screening for coronary heart disease109 
Routine screening with resting 
electrocardiography (ECG), exercise treadmill 
test (ETT), or electron-beam computerized 
tomography (EBCT) scanning for coronary 
calcium for either the presence of severe coronary 
artery stenosis (CAS) or the prediction of 
coronary heart disease (CHD) events in adults at 
low risk for CHD events 
D 
Routine screening with ECG, ETT, or EBCT 
scanning for coronary calcium for either the 
presence of severe CAS or the prediction of CHD 
events in adults at increased risk for CHD events 
I 
Letter Score 
• The “D” recommendation against routine ECG screening in asymptomatic children, 
adolescents, and young adults was not updated in 2004. 
• In 1996, insufficient evidence was available to recommend for or against screening 
middle-aged and older men for CAD using ECG. In 2004, a “D” recommendation was 
issued against screening in low-risk adults and a “I” statement was issued for high-risk 
adults.  This change corresponds to a letter score of “neutral to negative” 
Intensity Score 
• Not applicable 
Example 19 
Previous Recommendations Updated Recommendations 
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 1996: Counseling to promote a healthy diet31 
Counseling patients to change dietary habits by 
specially trained counselors (including by trained 
providers in the office or by referral to registered 
dietitians or qualified nutritionists) 
B 
Insufficient evidence that nutritional counseling 
by physicians, as opposed to counseling by 
dietitians or community interventions, is effective 
in changing the dietary habits of patients 
C 
 
2003: Behavioral counseling in primary care to 
promote a healthy diet61 
Routine behavioral counseling to promote a 
healthy diet in unselected patients in primary care 
settings 
I 
Intensive behavioral dietary counseling for adult 
patients with hyperlipidemia and other known 
risk factors for cardiovascular and diet-related 
chronic disease delivered by primary care 
clinicians or by referral to other specialists, such 
as nutritionists or dietitians 
B 
Letter Score 
• In 1996, the Task Force issued a “B” recommendation for dietary counseling in the 
general primary care population by specially trained educators when physicians “lack 
the time or skills to perform a complete dietary history, to address potential barriers to 
changes in eating habits, and to offer specific guidance on meal planning and food 
selection and preparation.” 
• Conversely, in 2003, the Task Force issued a “I” statement for routine behavioral 
counseling to promote a healthy diet in the general population.   
• For patients with hyperlipidemia and other risk factors for cardiovascular disease and 
diet-related chronic disease, the Task Force issued “B” recommendation for intensive 
behavioral dietary counseling. 
• The change from a “B” recommendation for dietary counseling in the general primary 
care population to an “I” statement for unselected patients and a “B” recommendation 
for a subpopulation of patients corresponds to a “positive to less strongly positive” 
letter score. 
Intensity Score 
• Compared to 1996, the updated recommendations in favor behavioral counseling apply 
to a smaller population. Thus, an intensity score of  “decreased intensity” is 
appropriate. 
Example 20 
Previous Recommendations Updated Recommendations 
 
2008: Screening for prostate cancer110 
Screening for prostate cancer in men age 75 years 
or older 
D 
Screening for prostate cancer in men younger 
than age 75 years. 
I 
 2012: Screening for prostate cancer25  




• The “D” recommendation against screening for prostate cancer in men age 75 years 
and older did not change.  
• The “I” statement issued for men younger than age 75 years changed to a “D” 
recommendation against screening in this population.  
• Thus, the overall “D” recommendation against screening in a subpopulation of men 
became more negative with the change from and “I” statement to a “D” 
recommendation against screening in men younger than age 75 years. As such, the 




• Not applicable because the Task Force did not issue recommendations in favor of 
prostate cancer screening in any population. 
Example 21 
Previous Recommendations Updated Recommendations 
 
2002: Screening for osteoporosis in postmenopausal 
women111 
Screening in postmenopausal women who are 
younger than 60 years of age or in women 60 to 
64 years of age who are not at increased risk for 
osteoporotic fractures 
C 
Routinely screening for osteoporosis in women 
65 years of age and older and routine screening 
beginning at 60 years of age for women at 
increased risk for osteoporotic fractures 
B 
 2011: Screening for osteoporosis112 
Screening for osteoporosis in women aged 65 
years and older and in younger women whose 
fracture risk is equal to or greater than that of a 
65-year-old white woman who has no additional 
risk factors 
B 
Screening for osteoporosis in men I 
Letter Score 
• The “B” recommendation for routinely screening women aged 65 years and older for 
osteoporosis did not change.  
• In 2002, the Task Force issued a “B” recommendation for screening women at 
increased risk for osteoporotic fractures beginning at 60 years of age.  In 2011, this “B” 
recommendation was generalized to include all younger women at increased fracture 
risk (namely, younger women whose fracture risk is equal to or greater than that of a 
65-year-old white woman who has no additional risk factors).  
• In 2011, the Task Force did not update its “C” recommendation for screening younger 
women who are not at increased risk for fractures.  The Task Force additionally 
addressed screening for osteoporosis in men, a population that had not previously been 
issued a recommendation.  
• Overall, the “B” recommendation in favor of screening women aged 65 and older and a 
set of younger women at increased fracture risk did not change. As such, a letter score 
of “positive to equally as positive” is appropriate.  
Intensity Score 
• Notably, the Task Force expanded its “B” recommendation for screening women 
younger than 65 to include all women with a 10-year fracture risk equal to or greater 
than that of a 65-year-old white women without additional risk forces. The previous 
“B” recommendation for younger women was limited to women 60 to 64 years of age 
at increased fracture risk. Thus, an intensity score of  “increased intensity” is 
appropriate. 
Example 22 
Previous Recommendations Updated Recommendations 
 
2004: Screening for visual impairment in children 
younger than age 5 years113 
Screening to detect amblyopia, strabismus, and 
defects in visual acuity in children younger than 
age 5 years 
B 
 
2011: Vision screening for children ages 1-5114  
Vision screening for children <3 years of age I 
Vision screening for all children at least once 
between the ages of 3 and 5 years, to detect the 





• In 2011, the Task Force provided more guidance on the appropriate screening age for 
vision screening in children by issuing two separate recommendations based on age 
group. The overall “B” recommendation for screening children younger than age 5 
years, however, did not change. As such, a letter score of “positive to equally as 
positive” is appropriate. 
Intensity Score 
• In 2004, the Task Force did not provide guidance on the optimal age to begin vision 
screening. The Task commented that it was “unable to determine the optimal screening 
tests, periodicity of screening, or technical proficiency required of the screening 
clinician.” Conversely, in 2011, the Task Force issued separate recommendations for 
vision screening in children between the ages of 3 and 5 years of age (“B” 
recommendation for screening at least once) and in children less than 3 years (“I” 
statement).  Since the 2004 recommendation did not provide clear guidance on the 
optimal age for screening, however, a clear change in the population issued a positive 
recommendation for screening cannot be inferred.  Thus, an intensity score of “same 
intensity” is appropriate. 
Example 23 
Previous Recommendations Updated Recommendations 
 
1996: Screening for visual impairment31 
Vision screening for amblyopia and strabismus in 
preschool children once before entering school, 
preferably between ages 3 and 4 years 
B 
 
2004: Screening for visual impairment in children 
younger than age 5 years113 
Screening to detect amblyopia, strabismus, and 
defects in visual acuity in children younger than 
age 5 years 
B 
Letter Score 
• The “B” recommendation for screening preschool children for visual impairment did 
not change. As such, a letter score of “positive to equally as positive” is appropriate. 
Intensity Score 
• In 1996, the Task Force recommended vision screening for stabismus and amblyopia in 
children once before entering school.  The Task Force noted that this screening should 
preferably occur between the ages 3 and 4 years since “detecting occult visual 
disorders by screening tests in children under 3 years of age has generally been 
unsuccessful.” As discussed above (Example 22), the 2004 recommendation statement 
did not provide clear guidance on the periodicity or optimal age for vision screening in 
children.  For this reason, no clear changes in the intensity of the recommended 
screening intervention can be inferred. Thus, an intensity score of “same intensity” is 
appropriate. 
Example 24 




1996: Screening for asymptomatic bacteriuria31 
Screening for asymptomatic bacteriuria with 
urine culture in pregnant women at 12 to 16 
weeks of gestation 
A 
Routine screening for asymptomatic bacteriuria 
with leukocyte esterase or nitrite testing in 
pregnant women  
D 
Insufficient evidence to recommend for or against 
routine screening for asymptomatic bacteriuria 
with leukocyte esterase or nitrite testing in non-
institutionalized elderly women 
C 
Insufficient evidence to recommend for or against 
routine screening for asymptomatic bacteriuria 
with leukocyte esterase or nitrite testing in 
women with diabetes 
C 
Routine screening for bacteriuria with leukocyte 
esterase or nitrite testing in school-aged girls  
E 
Routine screening for bacteriuria with leukocyte 
esterase or nitrite testing in institutionalized 
elderly persons  
E 
Routine screening for bacteriuria with leukocyte 
esterase or nitrite testing in other asymptomatic 
children, adolescents, and adults  
D 
Screening for asymptomatic bacteriuria with 
routine urine microscopy 
D 
 
2004: Screening for asymptomatic bacteriuria in 
adults115 
Screening for asymptomatic bacteriuria with 
urine culture in pregnant women at 12 to 16 
weeks gestation. 
A 
Screening for asymptomatic bacteriuria in men 
and nonpregnant women. 
D 
Letter Score 
• The updated 2004 recommendation statement focuses on adults; whereas, the Task 
Force additionally issued recommendations for children in 1996. This change 
represents a splitting of the topic. Notably, the Task Force has not updated its 
recommendations for screening for asymptomatic bacteriuria in children, and the topic 
does not appear to be active.   
• The “A” recommendation for screening pregnant women for asymptomatic bacteriuria 
with urine culture at 12 to 16 weeks gestation did not change. 
• Notably, the Task Force did not update the 1996 “D” recommendation for routine 
screening in pregnant women with leukocyte esterase or nitrite testing. The 2004 
recommendation statement, however, does note that “dipstick analysis and direct 
microscopy have poor positive predictive value and negative predictive in detecting 
bacteriuria in asymptomatic persons” and specifically recommends screening using 
urine culture in pregnant women.  
• In 2004, the Task Force issued a single “D” recommendation against screening in 
asymptomatic men and non-pregnant women. Previously, several individual 
recommendations had been issued for routine screening in subpopulations of 
asymptomatic persons. Notably, this recommendation applies to asymptomatic non-
institutionalized elderly women and women with diabetes, subpopulations for which 
the Task Force had previously found insufficient evidence to recommend for or against 
routine screening.  The change in letter grade for these subpopulations represents the 
only clear difference in comparable recommendations between the two sets of 
recommendations for screening asymptomatic bacteriuria. 
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• Recall Rule 5: If previously issued and updated recommendation statements issue both 
positive and negative recommendations for an intervention in different subpopulations, 
prioritize the positive recommendations in the assignment of a letter score. 
• Application of Rule 5:  Both recommendation statements issued “A” 
recommendations in favor of screening in pregnant women and “D” recommendations 
against screening in subpopulations of asymptomatic persons. Application of Rule 5 
results in the selection of a variant of the “positive to positive” letter score. Given the 
change from insufficient evidence recommendations for screening in non-
institutionalized elderly women and women with diabetes to the inclusion of these 
subpopulations in the updated “D” recommendation against screening, a letter score of 
“positive to less strongly positive” is appropriate.  
Intensity Score 
• Rule 3: Only consider changes in the intensity of interventions and populations 
receiving positive recommendations when assigning an intensity score. 
• Application of Rule 3:  The “A” recommendation in favor of screening pregnant 
women at 12 to 16 weeks gestation with urine culture did not change. Thus, application 
of Rule 3 leads to the selection of “same intensity” as the intensity score.  
Example 25 
Previous Recommendations Updated Recommendations 
 
2008:  Screening for lipid disorders in adults17 
Screening men aged 35 and older for lipid 
disorders 
A 
Screening men aged 20-35 for lipid disorders if 
they are at increased risk for coronary heart 
disease 
B 
Screening women aged 45 and older for lipid 
disorders if they are at increased risk for coronary 
heart disease 
A 
Screening women aged 20-45 for lipid disorders 
if they are at increased risk for coronary heart 
disease 
B 
Screening for lipid disorders in men aged 20 to 
35, or in women aged 20 and older who are not at 
increased risk for coronary heart disease 
C 
 
2016:  Statin use for the primary prevention of 
cardiovascular disease in adults16 
Initiating use of low- to moderate-dose statins in 
adults aged 40 to 75 years without a history of 
CVD who have one or more CVD risk factors 
and a calculated 10-year CVD event risk of 10% 
or greater 
B 
Initiating use of  low- to moderate-dose statins to 
adults aged 40 to 75 years without a history of 
CVD who have one or more CVD risk factors 
and a calculated 10-year CVD event risk of 7.5% 
to 10% 
C 
Initiating statin use in adults 76 years and older I 
Letter Score 
• The updated 2016 recommendations pertain to the use of statins; whereas, the 
previously issued recommendations pertain to screening for lipid disorders. In making 
this change, the Task Force noted that “in the age range in which statins have been 
studied for primary prevention, universal screening for elevated lipid levels is required 
[to help identify persons who may benefit from statin therapy].” 
• Since both recommendation statements either directly recommend (2008) or imply a 
recommendation (2016) in favor of lipid screening in a subset of adults, a variant of the 
“positive to positive” letter score is appropriate. Because the 2016 recommendation 
statement does not provide specific recommendations (and associated letter grades) for 
which adults should be screened, however, the neutral letter score of “positive to 




• Beyond the implied recommendation of universal screening in a subset of adults, the 
2016 recommendation statement further recommends statin use in a subset of adults. In 
contrast, the 2008 recommendation statement only issued recommendations for 
screening and did not provide specific recommendations for the treatment of lipid 
disorders (beyond noting that the benefits of screening and treating lipid disorders 
outweigh the potential harms for specified subpopulations of adults). As such, an 
intensity score of “increased intensity” is appropriate. 
Example 26 
Previous Recommendations Updated Recommendations 
 
2001: Screening adults for lipid disorders116 
Screening men aged 35 years and older and 
women aged 45 years and older for lipid 
disorders and treating abnormal lipids in people 
who are at increased risk of coronary heart 
disease 
A 
Screening younger adults (men aged 20 to 35 
years and women aged 20 to 45 years) for lipid 
disorders if they have other risk factors for 
coronary heart disease 
B 
Screening for lipid disorders in younger adults 
(men aged 20 to 35 years or women aged 20 to 45 
years) in the absence of known risk factors for 
coronary heart disease 
C 
Total cholesterol and high-density lipoprotein 
cholesterol measurement as a part of routine 
screening for lipid disorders 
B 
Triglyceride measurement as a part of routine 
screening for lipid disorders. 
I 
 
2008: Screening for lipid disorders in adults17 
Screening men aged 35 and older for lipid 
disorders 
A 
Screening men aged 20-35 for lipid disorders if 
they are at increased risk for coronary heart 
disease 
B 
Screening women aged 45 and older for lipid 
disorders if they are at increased risk for coronary 
heart disease 
A 
Screening women aged 20-45 for lipid disorders 
if they are at increased risk for coronary heart 
disease 
B 
Screening for lipid disorders in men aged 20 to 
35, or in women aged 20 and older who are not at 
increased risk for coronary heart disease 
C 
Letter Score 
• The “A” recommendations for screening men age 35 and older for lipid disorders did 
not change. 
• The “C” recommendations for screening younger adults (men aged 20 to 35 years and 
women aged 20 to 45) who are not at increased risk of CHD did not change.  
• The “B” recommendations for screening men age 20 to 35 and women age 20 to 45 at 
increased risk for CHD did not change.  
• In 2008, the Task Force issued a “C” recommendation for screening women aged 20 
and older who are not at increased risk of coronary heart disease (CHD). Conversely, in 
2001, the Task Force recommended screening for all women aged 45 and older 
regardless of CHD risk. This difference implies a change from an “A” recommendation 
to a “C” recommendation for screening in women aged 45 and older who are not at 
increased CHD risk. 
• In 2008, the Task Force chose not to update its specific recommendations for the lab 
measurements to include as part of routine screening for lipid disorders. Instead, the 
Task Force discussed preferred screening tests in the “clinical considerations” section 
of the recommendation statement.  
79 
 
• Finally, in 2008, the Task Force removed language pertaining to the treatment of 
abnormal lipids from its recommendation summaries. Instead, discussion of treatment 
was included in other sections of the recommendation statement. 
• The change from an “A” recommendation to a “C” recommendation for screening 
women aged 45 and older who are not at increased CHD risk represents the only clear 
difference in comparable recommendations. As such, a letter score of “positive to less 
strongly positive” is appropriate. 
Intensity Score 
• The Task Force did not issue clear guidance or the optimal interval for screening or the 
appropriate age to stop screening in either recommendation statement. Furthermore, 
guidance for preferred screening tests did not change. 
• The change from an “A” recommendation to a “C” recommendation for screening 
women aged 45 and older who are not at increased CHD risk represents a decrease in 
the breadth of the population covered by a positive recommendation for screening. 







APPENDIX B:  Supplementary results 
 
 
Active USPSTF recommendations 
 
Table B1. Number of active recommendation statements 
and individual recommendations (as of June 1, 2017) 
Current number of active topics 84 
Current number of active recommendations 132 
Mean number of recommendations per topic 1.6 
 
 
Figure B1. Number of active topics with specific numbers  
of individual recommendations (as of June 1, 2017); n = 84 
 
Table B2. Number of active topics and individual recommendations published 
within the past five years (June 1, 2012 to June 1, 2017) 
Current number of active topics updated within the past five years 63 



































Number of  recommendations
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Table B3. Number and proportion of active recommendation statements 
with    recommendations of particular grades and published within the past 
five years (June 1, 2012 to June 1, 2017); total number of topics = 63 





At least one “A” recommendation 6 9.5% 
At least one “B” recommendation 25 39.7% 
At least one “A” or “B” recommendation 31 49.2% 
At least one “C” recommendation 6 9.5% 
At least one “D” recommendation 12 19.0% 
At least one “I” statement 36 57.1% 
 
Table B4. Number and proportion of currently active 
recommendation statements and individual 









2004 3 4 
2005 0 0 
2006 2 4 
2007 0 0 
2008 3 5 
2009 3 3 
2010 1 1 
2011 5 7 
2012 11 19 
2013 14 22 
2014 14 24 
2015 7 11 
2016 15 26 
2017 6 6 













Allocation of USPSTF recommendation grades over time 
 
Table B5.  Number and proportion of individual recommendations issued by year and letter 




A B C D I 
2017 1 (16.7%) 1 (16.7%) 0 (0.0%) 1 (16.7%) 3 (50.0%) 6 
2016 2 (7.7%) 7 (26.9%) 4 (15.4%) 2 (7.7%) 11 (42.3%) 26 
2015 3 (27.3%) 1 (9.1%) 0 (0.0%) 0 (0.0%) 7 (63.6%) 11 
2014 0 (0.0%) 10 (41.7%) 1 (4.2%) 3 (12.5%) 10 (41.7%) 24 
2013 2 (9.1%) 7 (31.8%) 0 (0.0%) 3 (13.6%) 10 (45.5%) 22 
2012 1 (5.3%) 3 (15.8%) 2 (10.5%) 9 (47.4%) 4 (21.1%) 19 
2011 1 (14.3%) 2 (28.6%) 0 (0.0%) 1 (14.3%) 3 (42.9%) 7 
2010 0 (0.0%) 1 (100.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 1 
2009 7 (30.4%) 3 (13.0%) 2 (8.7%) 2 (8.7%) 9 (39.1%) 23 
2008 6 (23.1%) 6 (23.1%) 2 (7.7%) 5 (19.2%) 7 (26.9%) 26 
2007 3 (27.3%) 1 (9.1%) 1 (9.1%) 2 (18.2%) 4 (36.4%) 11 
2006 0 (0.0%) 2 (18.2%) 0 (0.0%) 3 (27.3%) 6 (54.5%) 11 
2005 3 (15.8%) 3 (15.8%) 2 (10.5%) 8 (42.1%) 3 (15.8%) 19 
2004 5 (17.2%) 4 (13.8%) 0 (0.0%) 10 (34.5%) 10 (34.5%) 29 
2003 4 (16.7%) 4 (16.7%) 0 (0.0%) 3 (12.5%) 13 (54.2%) 24 
2002 2 (13.3%) 4 (26.7%) 1 (6.7%) 2 (13.3%) 6 (40.0%) 15 
2001 2 (14.3%) 3 (21.4%) 3 (21.4%) 1 (7.1%) 5 (35.7%) 14 
Total 42 (14.6%) 62 (21.5%) 18 (6.3%) 55 (19.1%) 111 (38.5%) 288 
 
Table B6.  Number and proportion of individual recommendations issued from 2001 to 2017 






A B A or B C D I 
2013-2017* 8 (9.0%) 26 (29.2%) 34 (38.2%) 5 (5.6%) 9 (10.1%) 41 (46.1%) 89 
2012-2017 9 (8.3%) 29 (26.9%) 38 (35.2%) 7 (6.5%) 18 (16.7%) 45 (41.7%) 108 
2008-2013 17 (17.3%) 22 (22.4%) 39 (39.8%) 6 (6.1%) 20 (20.4%) 33 (33.7%) 98 
2008-2012 15 (19.7%) 15 (19.7%) 30 (39.5%) 6 (7.9%) 17 (22.4%) 23 (30.3%) 76 
2007-2013 20 (18.3%) 23 (21.1%) 43 (39.4%) 7 (6.4%) 22 (20.2%) 37 (33.9%) 109 
2007-2012 18 (20.7%) 16 (18.4%) 34 (39.1%) 7 (8.0%) 19 (21.8%) 27 (31.0%) 87 
2006-2013 20 (16.7%) 25 (20.8%) 45 (37.5%) 7 (5.8%) 25 (20.8%) 43 (35.8%) 120 
2006-2012* 18 (18.4%) 18 (18.4%) 36 (36.7%) 7 (7.1%) 22 (22.4%) 33 (33.7%) 98 
2001-2007 19 (15.4%) 21 (17.1%) 40 (32.5%) 7 (5.7%) 29 (23.6%) 47 (38.2%) 123 
2001-2006 16 (14.3%) 20 (17.9%) 36 (32.1%) 6 (5.4%) 27 (24.1%) 43 (38.4%) 112 












Figure B2. Number of recommendation statements with  
specific numbers of individual recommendations issued 
from 2001 to 2017 (as of June 1, 2017); n = 164 
 
Table B7.  Number and proportion of recommendation statements containing at least one 
individual recommendation of particular grades stratified by time period. Data tabulated for all 
recommendation statements issued from 2001 to 2017 (as of June 1, 2017). *Data for these time 
periods presented in the main text. 
Time 
period 
Contains at least one recommendation of the following grades: 
Total 
A B A or B C D I 
2013-2017* 6 (10.7%) 24 (42.9%) 30 (53.6%) 5 (8.9%) 9 (16.1%) 33 (58.9%) 56 
2012-2017 7 (10.4%) 27 (40.3%) 34 (50.7%) 7 (10.4%) 14 (20.9%) 37 (55.2%) 67 
2008-2013 13 (22.8%) 21 (36.8%) 33 (57.9%) 6 (10.5%) 16 (28.1%) 29 (50.9%) 57 
2008-2012 12 (27.9%) 14 (32.6%) 25 (58.1%) 6 (14.0%) 13 (30.2%) 21 (48.8%) 43 
2007-2013 16 (25.0%) 22 (34.4%) 36 (56.3%) 7 (10.9%) 18 (28.1%) 32 (50.0%) 64 
2007-2012 15 (30.0%) 15 (30.0%) 28 (56.0%) 7 (14.0%) 15 (30.0%) 24 (48.0%) 50 
2006-2013 16 (23.2%) 23 (33.3%) 37 (53.6%) 7 (10.1%) 20 (29.0%) 36 (52.2%) 69 
2006-2012* 15 (27.3%) 16 (29.1%) 29 (52.7%) 7 (12.7%) 17 (30.9%) 28 (50.9%) 55 
2001-2007 16 (24.6%) 19 (29.2%) 30 (46.2%) 6 (9.2%) 25 (38.5%) 40 (61.5%) 65 
2001-2006 13 (22.4%) 18 (31.0%) 27 (46.6%) 5 (8.6%) 23 (39.7%) 37 (63.8%) 58 
2001-2005* 13 (24.5%) 17 (32.1%) 26 (49.1%) 5 (9.4%) 21 (39.6%) 33 (62.3%) 53 














































Table B8.  Number of individual recommendations issued by grade stratified by the certainty 
and magnitude of net benefit.  The corresponding letter grade is italicized.  Data is included for 
all  recommendations published from May 2007 to May 2017.*   
Certainty of 
net benefit 
Magnitude of net benefit 
Substantial Moderate Small Zero/Negative 
High 24 (A) 1 (B) 0 (C) 2 (D) 
Moderate 4 (B) 31 (B) 10 (C) 24 (D) 
Low 68 (I) 
*Several recommendations were not included in the counts above because they did not clearly 
specify either the certainty and/or magnitude of net benefit (n = 11).  For some of these 
recommendations (n = 5), the Task Force found “at least moderate” certainty and/or “at least 
moderate” magnitude of net benefit, but did not specify the precise level.9,11,16,90  Additionally, in 
2012 the Task Force concluded with high certainty that exercise or physical therapy has 
moderate net benefit and with moderate certainty that vitamin D supplementation has moderate 
net benefit in the prevention of falls in older adults, but issued a single “B” recommendation for 
these interventions.62  Finally, the Task Force did not clearly specify the certainty or magnitude 
of net benefit associated with its 2008 recommendations for screening for lipid disorders in 
adults (n = 5).17  
 
Point-based assessment of the directionality of topic updates over time  
 
Table B9.  Number and proportion of topic updates by directionality assessed using two different 
point-based methods from 2001 to 2017 (through June 1, 2017). Results tabulated by time 
periods; n = 142.  *Data for these time periods presented in the main text. 
Time 
period 
Directionality score 1 Directionality score 2 
Total 
Positive Neutral Negative Positive Neutral Negative 
2013-2017* 20 (40.8%) 23 (46.9%) 6 (12.2%) 14 (28.6%) 31 (63.3%) 4 (8.2%) 49 
2012-2017 22 (37.3%) 28 (47.5%) 9 (15.3%) 15 (25.4%) 37 (62.7%) 7 (11.9%) 59 
2008-2013 15 (29.4%) 26 (51.0%) 10 (19.6%) 11 (21.6%) 32 (62.7%) 8 (15.7%) 51 
2008-2012 9 (23.7%) 19 (50.0%) 10 (26.3%) 6 (15.8%) 24 (63.2%) 8 (21.1%) 38 
2007-2013 16 (28.1%) 29 (50.9%) 12 (21.1%) 11 (19.3%) 36 (63.2%) 10 (17.5%) 57 
2007-2012 10 (22.7%) 22 (50.0%) 12 (27.3%) 6 (13.6%) 28 (63.6%) 10 (22.7%) 44 
2006-2013 17 (28.8%) 29 (49.2%) 13 (22.0%) 11 (18.6%) 36 (61.0%) 12 (20.3%) 59 
2006-2012* 11 (23.9%) 22 (47.8%) 13 (28.3%) 6 (13.0%) 28 (60.9%) 12 (26.1%) 46 
2001-2007 16 (29.1%) 21 (38.2%) 18 (32.7%) 11 (20.0%) 26 (47.3%) 18 (32.7%) 55 
2001-2006 15 (30.6%) 18 (36.7%) 16 (32.7%) 11 (22.4%) 22 (44.9%) 16 (32.7%) 49 
2001-2005* 14 (29.8%) 18 (38.3%) 15 (31.9%) 11 (23.4%) 22 (46.8%) 14 (29.8%) 47 












Classification-based assessment of the directionality of topic updates over time 
 
Table B10.  Number and proportion of topic updates by letter 
score directionality issued from 2001 to 2017 (through June 1, 
2017). Results tabulated for different time periods; n = 142. *Data 
for these time periods presented in the main text. 
Time period 
Letter score directionality  
Total 
Positive Neutral Negative 
2013-2017* 10 (20.4%) 34 (69.4%) 5 (10.2%) 49 
2012-2017 11 (18.6%) 41 (69.5%) 7 (11.9%) 59 
2008-2013 12 (23.5%) 31 (60.8%) 8 (15.7%) 51 
2008-2012 6 (15.8%) 24 (63.2%) 8 (21.1%) 38 
2007-2013 12 (21.1%) 35 (61.4%) 10 (17.5%) 57 
2007-2012 6 (13.6%) 28 (63.6%) 10 (22.7%) 44 
2006-2013 12 (20.3%) 35 (59.3%) 12 (20.3%) 59 
2006-2012* 6 (13.0%) 28 (60.9%) 12 (26.1%) 46 
2001-2007 11 (20.0%) 27 (49.1%) 17 (30.9%) 55 
2001-2006 11 (22.4%) 23 (46.9%) 15 (30.6%) 49 
2001-2005* 11 (23.4%) 23 (48.9%) 13 (27.7%) 47 
Total 27 (19.0%) 85 (59.9%) 30 (21.1%) 142 
 
Table B11.  Number and proportion of topic updates by intensity 
score issued from 2001 to 2017 (through June 1, 2017). Results 
tabulated for different time periods; n =65. *Data for these time 
periods presented in the main text. 
Time period 
Intensity score  
Total 
Increased Same Decreased 
2013-2017* 5 (21.7%) 17 (73.9%) 1 (4.3%) 23 
2012-2017 5 (19.2%) 19 (73.1%) 2 (7.7%) 26 
2008-2013 2 (8.3%) 17 (70.8%) 5 (20.8%) 24 
2008-2012 1 (5.0%) 14 (70.0%) 5 (25.0%) 20 
2007-2013 2 (7.4%) 19 (70.4%) 6 (22.2%) 27 
2007-2012 1 (4.3%) 16 (69.6%) 6 (26.1%) 23 
2006-2013 2 (7.1%) 20 (71.4%) 6 (21.4%) 28 
2006-2012* 1 (4.2%) 17 (70.8%) 6 (25.0%) 24 
2001-2007 2 (9.1%) 14 (63.6%) 6 (27.3%) 22 
2001-2006 2 (10.5%) 12 (63.2%) 5 (26.3%) 19 
2001-2005* 2 (11.1%) 11 (61.1%) 5 (27.8%) 18 









Categorization of updated recommendation statements based on their relationships to 
previously published recommendation statements 
 
Table B12. Number and proportion of recommendation 
statements classified based on how the covered topic 
relates to previously issued recommendation statements 
Category Number (proportion) 
Linear topic update 99 (60.4%) 
Splitting of topics 39 (23.8%) 
Merging of topics 2 (1.2%) 
Mixing of topics 2 (1.2%) 
New topic 22 (13.4%) 
Total number of topic updates 164 
 
Dropped and new “D” recommendations against the use of preventive services 
 
Table B13. Dropped “D” recommendations  
Topic Year Recommendation dropped 
Screening for breast 
cancer 
2016 
In 2009, the USPSTF issued a “D” recommendation against 
teaching women how to perform breast self-examinations.  
The updated recommendation statement did not include a 
recommendation for this intervention.   
Screening for 
colorectal cancer  
2016 
In 2008, the USPSTF issued a “D” recommendation against 
screening for colorectal cancer in adults older than age 85 
years.  The updated recommendation statement did not a 
include a specific recommendation for this age group; 
however, a clause in the recommendation statement reads 
“the USPSTF does not recommend routine screening for 
colorectal cancer in adults 86 years and older.” 
Screening for syphilis 
infection in non-
pregnant adults and 
adolescents 
2016 
In 2004, the USPSTF issued a “D” recommendation against 
the routine screening of asymptomatic persons who are not at 
increased risk for syphilis infection. The updated 
recommendation statement did not include a 





In 2005, a “D” recommendation was issued against routine 
screening for gonorrhea infection in men and women who 
are at low risk for infection. The updated recommendation 
statement did not include a recommendation for screening 








Table B13. Continued. 
Screening for hepatitis 
B virus infection in 
nonpregnant 
adolescents and adults 
2014 
In 2004, a “D” recommendation was issued against routine 
screening for hepatitis B virus infection in the general 
asymptomatic population. The updated recommendation 
statement did not include a recommendation for this 
population. Instead, a “B” recommendation was issued for 
persons at high risk of infection. 
Screening for hepatitis 
C virus infection in 
adults 
2013 
In 2004, a “D’ recommendation was issued against routine 
screening for hepatitis C virus infection in asymptomatic 
adults who are not at increased risk for infection. The 
updated recommendation statement did not include a 
recommendation for screening in this population. Instead, a 
“B” recommendation was issued for persons at high risk for 
infection. 
Screening for coronary 
heart disease 
2004 
In 1996, a “D recommendation was issued for routine ECG 
screening as part of the periodic health visit or pre-
participation sports physical for asymptomatic children, 
adolescents, and young adults. The updated recommendation 
statement did not include a recommendation for screening in 
children or adolescents (only a recommendation against 
screening low-risk adults was issued).  
Screening for 
asymptomatic 
bacteriuria in adults 
2004 
In 1996, a “D” recommendation was issued for routine 
screening for asymptomatic bacteriuria in pregnant women 
with leukocyte esterase or nitrite testing.  The updated 
recommendation statement did not include a specific 
recommendation for this screening modality. Instead, the 
Task Force only updated the recommendation for screening 




















Table B14. New “D” recommendations for interventions or populations that had not 
previously been evaluated 
Topic Year New recommendation 
New “D” recommendations issued for updated topics 




New “D” recommendation against the use of aspirin for 
stroke prevention in women younger than 55 years and for 
myocardial infarction prevention in men younger than 45 
years. In 2002, only adults at increased risk of coronary heart 
disease were issued a recommendation. 
Screening for elevated 
blood lead levels in 
children and pregnant 
women 
2006 
New “D” recommendation against routine screening for 
elevated blood lead levels in asymptomatic children aged 1 
to 5 years who are at average risk. In 1996, only high-risk 
children were issued a screening recommendation. 
Screening for syphilis 
infection 
2004 
New “D” recommendation against the routine screening of 
asymptomatic persons who are not at increased risk for 
syphilis infection.  In 1996, recommendations were only 
given for high-risk persons and pregnant women. 
Screening for coronary 
heart disease 
2004 
New “D” recommendation against routine screening with 
electron-beam computerized tomography scanning for 
coronary calcium for either the presence of severe coronary 
artery stenosis or the prediction of coronary heart disease 
(CHD) events in adults at low risk for CHD events. In 1996, 
recommendations were only issued for resting ECG, 
ambulatory ECG, and exercise ECG.  
Screening for cervical 
cancer 
2003 
New “D” recommendation against routine Pap smear 
screening in women who have had a total hysterectomy for 
benign disease. In 1996, no recommendation was issued for 
this population.  
“D” recommendations issued for new topics 
Vitamin D and calcium 
supplementation to 
prevent fractures in 
adults 
2013 
New “D” recommendation against daily supplementation 
with 400 IU or less of vitamin D3 and 1000 mg or less of 
calcium for the primary prevention of fractures in 
noninstitutionalized postmenopausal women.  




New “D” recommendation against screening for chronic 
obstructive pulmonary disease in asymptomatic adults. 
Routine aspirin or 
nonsteroidal anti-
inflammatory drugs for 
the primary prevention 
of colorectal cancer 
2007 
New “D” recommendation against the routine use of aspirin 
and nonsteroidal anti-inflammatory drugs to prevent 












New “D” recommendation against routine genetic screening 
for hereditary hemochromatosis in the asymptomatic general 
population.  
Genetic risk assessment 
and BRCA mutation 




New “D” recommendation against routine referral for 
genetic counseling or routine breast cancer susceptibility 
gene (BRCA) testing for women whose family history is not 
associated with an increased risk for BRCA1 or BRCA2 
mutations. 
Screening for hepatitis 
C virus infection in 
adults 
2004 
New “D” recommendation against routine screening for 
hepatitis C virus infection in asymptomatic adults who are 
not at increased risk (general population) for infection 
Routine vitamin 
supplementation to 
prevent cancer and 
cardiovascular disease 
2003 
New “D” recommendation against the use of beta-carotene 
supplements, either alone or in combination, for the 




New “D” recommendation against the routine use of 
tamoxifen or raloxifene for the primary prevention of breast 
cancer in women at low or average risk for breast cancer 
Screening for bacterial 
vaginosis in pregnancy 
2001 
New “D” recommendation against routinely screening 



























New topics with recommendations in progress, referred topics, inactive topics, and other 















Table B15. Previously reviewed topics and new topics with recommendations in progress (as 
of June 1, 2017) 
Inactive topics 
• Screening of infants for hyperbilirubinemia (last updated in 2009117) 
• Screening for hearing loss in newborns (last updated in 2008118) 
• Screening for hemochromatosis (last updated in 2006119) 
• Counseling to prevent dental and periodontal disease (last updated in 199631) 
• Counseling to prevent gynecological cancers (last updated in 199631) 
• Screening for rubella (last updated in 199631) 
Referred topics 
• Screening for congenital hyperthyroidism (last updated in 2008120; referred to the 
Discretionary Advisory Committee on Heritable Disorders in Newborns and Children 
[DACHDNC]) 
• Screening for phenylketonuria in newborns (last updated in 2008121; referred to 
DACHDNC) 
• Screening for sickle cell disease in newborns (last updated in 2007122; referred to 
DACHDNC) 
• Counseling about the proper use of motor vehicle occupant restraints and avoidance of 
alcohol use while driving (last updated in 200760; referred to the Community Preventive 
Services Task Force [CPSTF]) 
• Prevention of youth violence (last updated in 199631; referred to the CPSTF) 
• Immunizations for adults (last updated in 199631; referred to the Advisory Committee on 
Immunization Practices [ACIP]) 
• Immunization for children (last updated in 199631; referred to ACIP)  
New topics with recommendations in progress (as of June 1, 2017)123 
• Interventions to prevent perinatal depression 
• Behavioral and pharmacotherapy interventions for weight loss to prevent obesity-related 
morbidity and mortality in adults 




Table B15. Continued. 
Topics reviewed in the 2nd edition of the Guide to Clinical Preventive Services31, but not 
currently listed on the USPSTF website (as of June 1, 2017) 
• Screening with immune markers to identify asymptomatic individuals at risk for 
developing insulin-dependent diabetes mellitus (included in a broader chapter on 
screening for diabetes) 
• Screening for iron deficiency anemia in the general population (included in a broader 
chapter on screening for iron deficiency anemia including iron prophylaxis; current 
topics focus on young children and pregnant women) 
• Counseling families to control lead dust exposure and optimize diet to reduce lead 
absorption (included in a broader chapter screening for elevated lead levels in childhood 
and pregnancy) 
• Routine use of acyclovir in pregnant women with recurrent herpes; Counseling of women 
who have no history of genital herpes, but whose partners have a positive history, to use 
condoms or abstain from intercourse during pregnancy (both included in a broader 
chapter on screening and counseling for genital herpes simplex) 
• Screening for visual impairment in older children, adolescents, and adults (included in a 
broader chapter on screening for visual impairment; current topics focus on young 
children and older adults) 
• Screening for hearing loss in children, adolescents, and working-age adults (included in a 
broader chapter on screening for hearing impairment; current topics focus on newborns 
and older adults) 
• Screening ultrasonography in pregnancy 
• Use of intrapartum electronic fetal monitoring in pregnancy 
• Use of home uterine activity monitoring in pregnancy 
• Screening for down syndrome 
• Screening for neural tube defects (included in a broader chapter which issued 
recommendations for folic acid prophylaxis; current topic only includes 
recommendations for folic acid supplementation) 
• Screening for hemoglobinopathies (a subsequently issued recommendation statement 
focused specifically on screening for sickle cell disease in newborns; this topic has since 
been referred to the DACHDNC) 
• Training primary care clinicians to recognize and treat affective disorders in order to 
prevent suicide (included in broader chapter on screening for suicide risk) 
• Counseling patients to use motorcycle helmets; Counseling patients on safe pedestrian 
behaviors (both included in broader chapter on the prevention of motor vehicle injuries) 
• Counseling adolescents, adults, and parents of young children on measures to reduce 
injury risk (included in a broader chapter on counseling to prevent household and 
recreational injuries; this chapter also included recommendations for several specific 
injury prevention interventions on the basis of the evidence for their efficacy of risk 
reduction) 
• Counseling to prevent low back pain 
• Counseling to prevent unintended pregnancy 
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